amikacin has been researched along with Bacterial Disease in 392 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 240 (61.22) | 18.7374 |
| 1990's | 79 (20.15) | 18.2507 |
| 2000's | 37 (9.44) | 29.6817 |
| 2010's | 29 (7.40) | 24.3611 |
| 2020's | 7 (1.79) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HZ; Hong, B; Jiang, JD; Li, CR; Li, Y; Li, ZR; Lou, RH; Sun, CH; Wang, YM; Yang, XY; You, XF; Yuan, M; Zhang, WX; Zhao, LX | 1 |
| Bucki, R; Byfield, FJ; Cruz, K; Diamond, SL; Fein, DE; Janmey, PA; Kulakowska, A; Leszczynska, K; Namiot, A; Namiot, Z; Savage, PB; Won, E | 1 |
| Gu, W; Wang, S | 1 |
| Almajan, GL; Bancescu, G; Barbuceanu, F; Barbuceanu, SF; Draghici, C; Saramet, G | 1 |
| Li, X; Ma, S | 1 |
| Almeida, MCS; Barreto, FS; Braz-Filho, R; Costa, JGM; da S Souza, LG; de Brito, ES; de Moraes, MO; Lemos, TLG; Ribeiro, PRV; Rodrigues, FFG; Silva, AMS; Silva, VLM | 1 |
| Dwoskin, LP; Garneau-Tsodikova, S; Green, KD; Kril, LM; Kwiatkowski, S; Nickell, JR; Shrestha, SK; Sviripa, VM; Watt, DS | 1 |
| Agoons, BB; Etoga, MCE; Jingi, AM; Mbanya, JC; Mekobe, FM; Ngassam, E; Sobngwi, E; Yefou, MD | 1 |
| Babapoor, E; Dezfulian, M; Rahmati, M | 1 |
| Feldmann, C; Redinger, N; Rutschmann, M; Schaible, UE | 1 |
| Basmaci, R; Biscardi, S; Cohen, R; Dubos, F; Faye, A; Grimprel, E; Madhi, F; Raymond, J; Romain, AS; Ros, B; Rybak, A; Werner, A | 1 |
| Almirante, B; Basas, J; Gainza, E; Gainza, G; Gavaldà, J; Gomis, X; Hernandez, RM; Igartua, M; Palau, M; Pastor, M; Vairo, C | 1 |
| Raut, A; Sharma, D; Suvarna, V | 1 |
| Feng, L; Liu, B; Maszewska, A; Moryl, M; Rozalski, A; Wu, J | 1 |
| Kelly, LE; Murthy, P; Shah, PS; Shivananda, S; Srinivasjois, R | 1 |
| Ramirez, MS; Tolmasky, ME | 1 |
| Bernkop-Schnürch, A; Ellemunter, H; Fontana, S; Griesser, J; Gutierrez, AM; Hetényi, G; Niedermayr, K; Szabó, P | 1 |
| Chung, HS; Hwang, EC; Jung, SI; Kim, JW; Kim, MS; Kwon, DD; Son, KC | 1 |
| Bethou, A; Biswal, N; Mathai, B; Ramasamy, S | 1 |
| Baniel, J; Goldberg, H; Kedar, D; Mano, R; Stabholz, Y; Yossepowitch, O | 1 |
| Jain, N; Tewari, VV | 1 |
| Aubert, C; Barbar, S; Bastide, S; Elotmani, L; Lefrant, JY; Lloret, S; Molinari, N; Muller, L; Nucci, B; Polge, A; Pradel, G; Roberts, JA; Roger, C; Saissi, G | 1 |
| Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S | 1 |
| Escuder-Gilabert, L; Ezquer-Garin, C; Lisart, RF; Martín-Biosca, Y; Medina-Hernández, MJ; Sagrado, S | 1 |
| Glikman, D; Hoffmann, Y; Kassem, DF; Ocampo, S; Salomon, L; Shahar, N; Zonis, Z | 1 |
| Lee, DG; Lee, SH; Lee, Y; Yoo, KH | 1 |
| Carroll, K; Cohen, DM; Cross, CP; Feeney, MP; Garinis, AC; Gold, JA; Hunter, LL; Keefe, DH; Putterman, DB; Srikanth, P; Steyger, PS | 1 |
| Bavbek, N; Bayrak, O; Catal, F; Karabel, D; Karabel, M; Odemis, E; Uz, E | 1 |
| Bayraktar, MR; Işeri, L | 1 |
| Giannakakis, T; Hatzitolios, A; Kollaras, P; Kordosis, T; Metallidis, S; Nikolaidis, J; Nikolaidis, P; Seitanidis, B | 1 |
| Esposito, S; Farina, D; Gallo, E; Gastaldo, L; Manzoni, P; Principi, N | 1 |
| Ardanuy, R; Domínguez-Gil, A; Lanao, JM; Mar Fernández de Gatta, MD; Moreno, SR; Victoria Calvo, M | 1 |
| Carlesse, FA; da Silva, KV; de Martino Lee, ML; Luisi, FA; Pereira, CA; Petrilli, AS | 1 |
| Barthélémy, C; De Broucker, M; Décaudin, B; Dubreuil, L; Lannoy, D; Odou, MF; Odou, P; Poret, E; Simon, N | 1 |
| Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N | 1 |
| Brambilla, P; Brucato, A; Curri, SF; Dieli, M; Ferrazzi, P; Pedrotti, P; Pericotti, S; Senni, M; Simon, C; Suter, F | 1 |
| Bratt, GW; Dille, MF; Fausti, SA; Gallun, F; Gordon, JS; Helt, WJ; Konrad-Martin, D; Reavis, KM | 1 |
| Haggard, WO; Noel, SP; Stinner, DJ; Watson, JT; Wenke, JC | 1 |
| Hayashi, T; Kimiwada, T; Shirane, R; Tominaga, T; Yokosawa, M | 1 |
| Batura, D; Bo Nielsen, P; Charlett, A; Rao, GG | 1 |
| Burd, EM; Ribner, BS; Shak, JR; Whitaker, JA | 1 |
| Alfandari, S; Allorge, D; Berthon, C; Blondiaux, N; Cliquennois, E; Gay, J; Herbaux, C; Mareville, J; Pasquier, F | 1 |
| Aparicio, J; Bosch, C; Galan, A; Giner, V; Juan, O; Molins, C; Montalar, J; Segura, A | 1 |
| Barr-Alí, M; Burgaleta, C; De Miguel, D; García-Suárez, J; Hernanz, N; Krsnik, I; Reyes, E | 1 |
| Blot, N; Marie-Cardine, A; Schneider, P; Tron, P; Vannier, JP | 1 |
| Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Cypriano, M; Dantas, LS; Lee, LM; Petrilli, AS; Pires Pereira, CA; Torres B Silva, KV; Vercillo Luisi, MF | 1 |
| Abdulkadyrov, KM; Chebotkevich, VN; Chudanova, TV | 1 |
| Akgül, H; Bornfeld, N; Brockmann, C; Höck, K; Laube, T; Schilling, H; Schüler, A | 1 |
| Perederko, LV; Polikarpova, SV; Postnikov, SS; Semykin, SIu | 1 |
| Allegaert, K; Cossey, V; Devlieger, H; Langhendries, JP; Naulaers, G; Van Overmeire, B; Vanhole, C | 1 |
| Ahmed, U; Burney, IA; Khan, MA; Shamim, A; Siddiqui, BK; Yosuf, MA; Zakiullah, N | 1 |
| Debbia, E; Nicoletti, G; Schito, GC; Stefani, S | 1 |
| Hugelschaffer, C; Kochendorfer, P; Kujath, P; Lang, J | 1 |
| Allegaert, K; Anderson, BJ; Cossey, V; Holford, NH | 1 |
| Chen, TA; Lai, KH; Lin, WJ; Lo, GH | 1 |
| Almog, Y; Buczynski, AZ; Cannon, J; Jayawardena, V; Markantonis, SL; Peloquin, C; Soni, BM; Vaidyanathan, S; Vidal, J; Wyndaele, JJ | 1 |
| Acar, B; Aysev, D; Ekim, M; Güriz, H; Kavaz, A; Ozçakar, ZB; Oztürk, B; Yalçinkaya, F; Yüksel, S | 1 |
| Lefor, AT; Morita, R; Nabeshima, T; Yoshida, M | 1 |
| Ginalska, G; Kowalczuk, D; Osińska, M | 1 |
| Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M | 1 |
| Zagólski, O | 1 |
| Hamidah, A; Jamal, R; Nordiah, AJ; Rizal, AM | 1 |
| Duttagupta, S; Kochhar, P; Sarkar, S; Suvarna, V | 1 |
| Aytac, S; Cengiz, AB; Cetin, M; Ceyhan, M; Secmeer, G; Tuncer, M; Yetgin, S; Yildirim, I | 1 |
| Charrel, CT; François, G; Gouin, F; Granthil, C; Martin, C; Savin, B | 1 |
| Camboulives, J; Charrel, C; Olivesi, A; Unal, D | 1 |
| Ezaki, K; Horikoshi, N; Ikeda, K; Inagaki, J; Inoue, K; Miyamoto, H; Nakada, H; Ogawa, M; Okada, Y; Usui, N | 1 |
| De Jongh, CA; Finley, RS; Fortner, CL; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH | 1 |
| Gale, RP; Hewitt, WL; Ho, WG; Winston, DJ; Young, LS | 1 |
| Klastersky, J | 3 |
| Bernard, C; Gaya, H; Klastersky, J; Ryff, JC; Zinner, SH | 1 |
| Chavanet, P; Cortet, P; Guy, H; Kazmierczak, A; Portier, H | 1 |
| Bryon, PA; Coiffier, B; Extra, JM; Ffrench, M; Fiere, D; Gonnaud, P; Guyotat, D; Imbert, C; Rebattu, P; Viala, JJ; Vuvan, H | 1 |
| Jacquillat, C; Khayat, D; Maral, J | 1 |
| Gaya, H | 3 |
| Fortner, CL; Newman, KA; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH | 1 |
| Barnes, RC; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ; Young, LS | 1 |
| Hasegawa, S; Nakao, I | 1 |
| Kumor, KM; Lietman, PS; McDonald, JM | 1 |
| Barrera, V; Buatas, A; Martinez, P; Pinero, A; Sinues, B | 1 |
| Buesing, MA; Jorgensen, JH | 1 |
| Hattori, Y; Kobayashi, F; Koshi, T; Mitsuhashi, S; Oda, T; Saino, Y | 1 |
| Cross, AS; Kopecko, DJ; Opal, S | 1 |
| Du, JZ | 1 |
| Caretti, D; Escudero, A; Fernández-Garese, D; Fernández-Rañada, J; Olmeda, F; Vázquez, L | 1 |
| Hill, B; Holm, SE; Löwestad, A; Maller, R; Vikerfors, T | 1 |
| Cohen, T; Drucker, M; Reisner, SH; Wielunsky, E | 1 |
| Hanamure, Y; Hashimoto, M; Iida, F; Kiyota, R; Kurono, Y; Maeyama, T; Ogawa, K; Ohhori, Y | 1 |
| Azanza Perea, JR; Cuena Boy, R; Echeverría Echepare, LM; Honorato Pérez, J | 1 |
| Lönnqvist, B; Palmblad, J | 1 |
| Cone, LA | 1 |
| Jimenez, EM; Lindquist, LB; Montgomerie, JZ; Morrow, JW; Sapico, FL | 1 |
| Britten, J; Caplan, E; deJongh, CA; Finley, RS; Fortner, CL; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH | 1 |
| Cagle, GD; Schlech, BA | 1 |
| de Jongh, CA; Moody, MM; Schimpff, SC; Tillman, GL | 1 |
| Edson, RS; Keys, TF | 1 |
| Neu, HC | 1 |
| Hanna, C; McDougal, RL; Roy, FH; Wingfield, DL | 1 |
| McVie, JG; Mullinger, BM; Stuart, JF | 1 |
| Iwai, N; Miyazu, M; Osuga, T; Sasaki, A | 1 |
| Kawahata, Y; Murao, A; Nishino, T; Obana, Y; Tanino, T | 1 |
| Miyao, S; Mou, M; Shinonome, S; Takakuwa, M; Tsuchiya, J | 1 |
| Cortelezzi, A; Penagini, R; Pogliani, EM; Radaelli, F | 1 |
| Bock, BV; Edelstein, PH; Meyer, RD | 1 |
| Barza, M; Gorbach, SL; Lauermann, MW; Tally, FP | 1 |
| Gorbach, SL; Kellum, JM; McGowan, K; O'Donnell, TF; Tally, FP | 1 |
| Canafax, DM; Peterson, PK; Simmons, RL; Tofte, RW | 1 |
| Gorbach, SL; McGowan, K | 1 |
| Connor, JD; James, HE; Walsh, JW; Wilson, HD | 1 |
| Deshpande, G; Faden, H; Grossi, M | 1 |
| Takigami, T | 1 |
| Shah, PM; Siegel, K; Stille, W | 1 |
| Hanada, S; Hashimoto, S; Iwahashi, M; Kato, Y; Kikuchi, H; Kodama, M; Matsumoto, M; Matsumoto, T; Nishioka, K; Nomura, K; Uematsu, T; Utsunomiya, A; Yunoki, K | 1 |
| Aoyagi, Y; Fujiwara, M; Fuse, I; Hanano, M; Hattori, A; Hirosawa, H; Kishi, K; Koike, T; Koyama, S; Moriyama, Y; Nagayama, R; Ohnishi, M; Sakai, C; Sanada, M; Shibata, A; Takahashi, H; Takahashi, M; Takai, K; Urushiyama, M | 1 |
| Hamada, H; Harada, K; Kurata, Y; Matsukawa, M; Mizushima, T; Nakamura, M; Ono, K; Tada, K; Yamamoto, T | 1 |
| Arvin, AM; Prober, CG; Yeager, AS | 1 |
| Ichimaru, M; Yamaguchi, H | 1 |
| Ishigami, S; Masaoka, T; Nakamura, H; Namiuchi, S; Shibata, H; Sonoda, T; Takubo, T; Ueda, T; Yoshitake, J | 1 |
| Asai, T; Fujioka, S; Ito, K; Oh, H; Sugiura, Y | 1 |
| Imura, M; Nakamura, H; Niwa, A; Okumoto, T; Sakata, K; Takatani, O; Yamamoto, K | 1 |
| Ando, Y; Aoki, I; Chen, DY; Negishi, M; Okamoto, S; Sotoyama, K; Sugiura, K; Uchida, H | 1 |
| Fujii, H; Shimizu, T | 1 |
| Hisataka, H; Kaneko, H; Owada, S; Saito, K; Watanabe, M; Yokomori, T | 1 |
| Dornák, F; Königová, R | 1 |
| Jastrup, B; Lomholt, P; Sørensen, IG; Vad, NK | 1 |
| Gorbach, SL; McGowan, K; Scheife, RT; Tally, FP | 1 |
| Deshpande, GN; Ettinger, LJ; Faden, HS; Freeman, AI; Grossi, M; Surgalla, M | 1 |
| Komori, T; Maekawa, I; Murata, M; Sone, Y; Suzuki, A; Yamazaki, T | 1 |
| Ishii, T; Kishimoto, S | 1 |
| Hirabayashi, N; Hirano, A; Hotta, T; Katoh, T; Maeda, H; Murate, T; Ohnishi, K; Shimizu, K; Utsumi, M; Yamada, H | 1 |
| Blevins, R; Bockbrader, H; Matzke, GR; Salem, N | 1 |
| Fabbrocini, V | 1 |
| Ahlmén, J; Alestig, K; Norrby, R; Trollfors, B | 1 |
| Flournoy, DJ; Perryman, FA | 1 |
| Hattori, Y; Kobayashi, F; Koshi, T; Saino, Y | 1 |
| Marmo, E | 1 |
| Breau, JL; Carcone, B; Charpentier, F; Dray, M; Israël, L | 1 |
| Andrea, R; Barnes, HG; Schneider, RK | 1 |
| Bhujwala, RA; Gupta, BL; Rattan, A; Singh, S | 1 |
| Catalin, J; Durand, A; Gauthier, T; Lacarelle, B; Marre, F; Villard, PH | 1 |
| Barboza, E; del Castillo, M; Gotuzzo, E; Yi, A | 1 |
| Artiges, V; Bouffet, E; Bouhour, D; Brunat Mentigny, M; Charra, C; Couillioud, D; Frappaz, D; Fuhrmann, C | 1 |
| Bolis, S; Bregani, R; Casaroli, I; Corneo, G; Lanzi, E; Mingozzi, S; Pioltelli, P; Pogliani, EM; Rossini, F; Viganó, F | 1 |
| Albanese, J; Domart, Y; Durbec, O; Gouin, F; Grès, JJ; Leroy, J; Martin, C; Papazian, L; Rollin, C; Veyssier, P | 1 |
| Kawada, E; Maehara, T; Matsushima, T; Morita, K; Murayama, K; Okamoto, K; Sadakata, H; Sawamura, M; Tamura, J; Tamura, K | 1 |
| Andremont, A; Chiche, D; Guiguet, M; Hayat, M; Lagrange, P; Lapierre, V; Marie, JP; Pico, JL; Richet, H; Tancrede, C | 1 |
| Fukuda, M; Hirashima, K | 1 |
| Jacoby, GA | 1 |
| Danisovicová, A; Drgona, L; Fuchsberger, P; Korec, S; Krcméry, V; Spánik, S; Svec, J | 1 |
| Gentile, G; Girmenia, C; Martino, P; Meloni, G; Micozzi, A; Nucci, M; Venditti, M | 1 |
| Hirakawa, K; Horiike, S; Kuzuyama, Y; Misawa, S; Nakai, H; Nishida, K; Seriu, T; Takashima, T; Tanaka, S; Tsuda, S | 1 |
| Beuscart, C; Mouton, YJ | 1 |
| Schuler, D | 1 |
| Principi, N; Viganò, A | 1 |
| Bressolle, F; Gomeni, R; Gouby, A; Guillaud, R; Joubert, P; Martinez, JM; Saissi, G | 1 |
| Delcenserie, R; Ducroix, JP; Yzet, T | 1 |
| Bobbaers, HJ; Peetermans, WE | 1 |
| Cordonnier, C; Delain, M; Delmer, A; Gardembas, M; Gres, JJ; Herbrecht, R; Ladeb, S; Moreau, P; Nalet, V; Pico, JL; Rollin, C | 1 |
| Donazzan, M; Ferri, F; Rose, C; Tellion, C | 1 |
| Itokazu, GS; Weinstein, RA | 1 |
| Behre, G; Hiddemann, W; Link, H; Maschmeyer, G; Meyer, P; Paaz, U; Wilhelm, M | 1 |
| Bessho, M; Endo, K; Fukuda, M; Hirashima, K; Kawai, N; Kobayashi, Y; Tominaga, K | 1 |
| Camlikiyi, H; Oktay, B; Ozyurt, M; Yavaşçaoğlu, I | 1 |
| Georgiou, A; Halkiadaki, D; Houpas, P; Karachalios, GN; Karachaliou, I; Papalimneou, V; Tziviskou, E | 1 |
| Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A | 1 |
| Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P | 1 |
| Alimena, G; Battistini, R; Breccia, M; Celesti, F; Cimino, G; Coppola, L; Girmenia, C; Latagliata, R; Mandelli, F; Morano, SG; Spadea, A; Tafuri, A; Tosti, S | 1 |
| Fluit, AC; Schmitz, FJ; Verhoef, J | 1 |
| Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi-Ferrini, P; Saccardi, R; Vannucchi, AM | 1 |
| Alimena, G; Celesti, F; Cimino, G; Coppola, L; D'Elia, GM; Girmenia, C; Latagliata, R; Mandelli, F; Mecarocci, S; Morano, SG; Spadea, A; Tafuri, A; Tosti, S | 1 |
| Aoki, K; Asano, S; Bessho, M; Fujita, A; Furusawa, S; Higashihara, M; Hirai, H; Hoshino, S; Hotta, T; Kitamura, K; Koike, M; Kuraishi, Y; Kurihara, I; Mizoguchi, H; Nagoshi, H; Nishimura, M; Nonaka, Y; Ohbayashi, Y; Omine, M; Oshimi, K; Ozawa, K; Suzuki, K; Takaku, F; Togawa, A; Urabe, A; Wakabayashi, Y | 1 |
| Masaoka, T | 1 |
| Bessho, M; Endo, K; Fukuda, M; Kawai, N; Maesaki, S; Takinami, S; Tominaga, K; Yamazaki, T | 1 |
| Aulagner, G; Bleyzac, N; Boutroy, MJ; Jelliffe, RW; Labaune, JM; Maire, P; Putet, G | 1 |
| Bucaneve, G; D'Antonio, D; Del Favero, A; Furno, P; Gentile, G; Mandelli, F; Martino, B; Martino, P; Menichetti, F; Micozzi, A; Ricci, P; Russo, D | 1 |
| Baka, M; Gombakis, N; Kafetzis, DA; Koliouskas, DE; Kosmidou, H; Malaka-Zafiriou, E; Maltezou, HC | 1 |
| Aulagner, G; Bleyzac, N; Corvaisier, S; Jelliffe, RW; Labaune, JM; Maire, P; Putet, G; Varnier, V | 1 |
| Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L | 1 |
| Hite, Y; Kopyt, M; Raveh, D; Rudensky, B; Sonnenblick, M; Yinnon, AM | 1 |
| Chudzik, GM; Price, KA | 1 |
| Crossley, K; Zaske, D | 1 |
| Moody, MR; Purvis, DS; Schimpff, SC; Wiernik, PH; Young, VM | 1 |
| Kimura, I; Kitagawa, N; Kitajima, K; Koui, F; Rai, MY; Takahashi, I; Tokioka, M; Yasui, M; Yorimitsu, S; Yoshizawa, K | 1 |
| Jusko, WJ; Plaut, ME; Schentag, JJ | 1 |
| Coiffier, B; Espinouse, D; Felman, P; Fiere, D; Reynaud, J; Vialard, L; Vu Van, H | 1 |
| Baughman, KL; Edwards, CQ; Lietman, PS; Rogers, JF; Smith, CR | 1 |
| De Kock, MA; Theron, FP | 1 |
| Axline, SG; Pesanti, EL; Rhame, FS; Yu, VL | 1 |
| Brewer, NS | 1 |
| Armani, U; Astengo, F; Azzena, D | 1 |
| Agudelo, N; de Vidal, EL; Manotas, R; Ramirez, JI; Trujillo, H; Uribe, A; Zapata, CT; Zuluaga, AI | 1 |
| Luft, FC | 1 |
| Appel, GB; Neu, HC | 1 |
| Hirshman, HP; Nagel, DA; Schurman, DJ | 1 |
| Gioannini, P | 1 |
| Hopefl, AW | 1 |
| Bender, JF; Fortner, CL; Hahn, DM; Love, LJ; Schimpff, SC; Standiford, HC; Wiernik, PH; Young, VM | 1 |
| Shah, PM; Stille, W | 1 |
| Alford, RH; Leonard, JM; McGee, ZA | 1 |
| Fu, KP; Jahre, JA; Neu, HC | 1 |
| Curtis, JE; Feld, R; Hasselback, R; Messner, HA; Tuffnell, PG | 1 |
| Bodey, GP; Keating, MJ; Rodriguez, V; Valdivieso, M | 1 |
| Kittikul, J; Limsuwan, A; Proomjanyakul, K; Saegcham, K; Siristonpun, Y; Tanpaichritr, D | 1 |
| Kafetzis, DA; Kosmidis, J; Papadatos, CJ; Sinaniotis, CA | 1 |
| Berman, SJ; Boughton, MT; Boughton, WH | 1 |
| Winterbauer, RH | 1 |
| Darrell, JH; Jones, AK; Want, SV | 1 |
| Aranyosi, J; Faragó, E; Gömöry, A; Juhász, I; Kiss, J; Mihóczy, L | 1 |
| Borowski, J; Dzierzanowska, D; Gruszecki, W; Musierowicz, A; Niedźwiecka, M | 1 |
| Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Sommers, HM | 1 |
| Cleary, TG; Culbert, S; Frankel, LS; Kohl, S; Kramer, WG; Pickering, LK | 1 |
| Doutre, LP; Gomez, E; Roche, MC | 1 |
| Bouvet, A; Desdoits, JM; Morel, CL; Souloy, J | 1 |
| Beaufils, F; Binger, E; Blum, C; Guillot, M; Lambert-Zechovsky, N; Mathieu, H | 1 |
| Auboyer, C; Bouletreau, P; Broussole, C; Flandrois, JP; Latarjet, J | 1 |
| Berger, SA; Pollock, AA; Rahal, JJ; Richmond, AS; Simberkoff, MS | 1 |
| Schiffman, DO | 1 |
| Hamada, M; Jikihara, T; Miyake, T; Tsuchiya, T; Umezawa, H; Umezawa, S | 1 |
| Black, RE; Hewitt, WL; Lau, WK; Linne, SR; Weinstein, RJ; Winston, DJ; Young, LS | 1 |
| Jevons, S; Moore, JW; Richardson, K; Ross, BC; Wright, JR | 1 |
| Parry, MF | 1 |
| Agbayani, MM; Jhaveri, RC; Khan, AJ | 1 |
| Dupont, C; Hammerberg, S; Marks, MI; Marks, S | 1 |
| Finegold, SM; Lewis, RP; Meyer, RD | 1 |
| Lüthy, R | 1 |
| Gregory, D; Hirschmann, JV | 1 |
| Sawchuk, RJ; Strate, RG; Zaske, DE | 1 |
| Borkowski, A; Czaplicki, M; Malewski, AW; Wencel, J | 1 |
| De Temmerman, P; Klastersky, J; Schoutens, E; Van Beerse, D; Yourassowsky, E | 1 |
| Hensgens, C; Klastersky, J; Meunier-Carpentier, F | 1 |
| Agre, K; Berman, E; Gooding, PG; Lane, AZ | 1 |
| McAllister, TA | 1 |
| Grunert, K; Koeppe, P; Langmaack, H; Lode, H | 2 |
| Berger, J; Cates, CY; Fox, LM; Gurwith, MJ; Lank, BA; Mathias, RG; McCullough, DW; Ronald, AR; Stiver, HG | 1 |
| Marget, W; Reindke, B; Versmold, H | 1 |
| Hewitt, WL; Young, LS | 1 |
| Doughty, SC; Greenberg, SB; Martin, RR | 1 |
| Bartlett, JG | 1 |
| Yow, MD | 1 |
| Mirhij, NJ; Myers, MG; Roberts, RJ | 1 |
| Dawkins, EJ; Geheber, CE; Kolb, LD; Stone, HH | 1 |
| Howard, JB; McCraken, GH; Mohs, E; Trujillo, H | 1 |
| Brumfitt, W; Daikos, GK; Hamilton-Miller, JM; Kosmidis, JC | 1 |
| Mazzei, T; Nicoletti, I; Paradiso, M; Periti, P | 1 |
| Dámaso, D; García-Iglesias, MC; Martínez-Beltrán, J; Moreno-López, M | 1 |
| Agudelo, N; De Vidal, EL; Londono, R; Manotas, R; Ramirez, JI; Trujillo, H; Uribe, A | 1 |
| Bodey, GP; Feld, R; Rodriguez, V; Valdivieso, M | 1 |
| Bartlett, JG; Gorbach, SL; Louie, TJ; O'Keefe, P; Tally, FP | 1 |
| Baert, L | 1 |
| Gleckman, R | 1 |
| Carmalt, ED; Finegold, SM; Lewis, RP; Meyer, RD | 1 |
| Kelly, MT; Matsen, JM | 1 |
| Betti, S; D'Antonio, D; D'Arcangelo, L; Dell'Isola, M; Fioritoni, G; Iacone, A; Mastrangelo, C; Natale, D; Recchia, A; Spadano, A | 1 |
| Kaufman, L; Mendes da Costa, P | 1 |
| Artal, A; Berrocal, A; Chacón, I; Espinosa, E; Feliu, J; García de Paredes, ML; González Barón, M; Montero, JM; Ordóñez, A; Zamora, P | 1 |
| Bosseray, A; Brion, JP; Hollard, D; Michallet, M; Micoud, M; Nicolini, F; Stahl, JP | 1 |
| Hulsey, RE; Mann, FA; Miller, GA; Pearson, RL; Perry, CR | 1 |
| Hattori, M; Sampi, K | 1 |
| Ba, M; Cissé, MF; Ouangre, AR; Samb, A; Sow, AI | 1 |
| Aucoin, D; Breuhaus, BA; Wichtel, MG | 1 |
| Fuchsberger, P; Horníková, M; Koza, I; Krcméry, V; Kusenda, Z; Mardiak, J; Spánik, S; Sufliarsky, J; Svec, J; Trupl, J | 1 |
| Björkholm, MJ; Engervall, PA; Günther, GC; Stiernstedt, GT | 1 |
| Anaissie, EJ; Berkey, P; Bodey, GP; Cabanillas, FF; Elting, L; Holmes, FA; Joshi, JH; Keating, MJ; Khardori, NM; Rolston, KV | 1 |
| Kearns, GL; Petersen, PO; Wells, TG | 1 |
| Jeschko, M; Pedrazzini, A; Schafroth, U; Schmid, L; Senn, H; Thürlimann, B; Wilder-Smith, C | 1 |
| Avlami, A; Meletis, J; Rombos, Y; Vayopoulos, G; Yataganas, X | 1 |
| Bauters, F; Blanc, C; Pollet, JP | 1 |
| Bassaris, HP; Chryssanthopoulos, C; Melekos, MD; Skoutelis, A | 1 |
| Calandra, T; Gaya, H; Glauser, M; Klastersky, J; Meunier, F; Viscoli, C; Zinner, SH | 1 |
| Barretta, MA; Boni, L; Castagnola, E; Dudley, M; Ferrea, G; Lanino, E; Loy, A; Moroni, C; Somenzi, M; Viscoli, C | 1 |
| Ahrne, H; Eilard, T; Eriksson, I; Lausen, I; Maller, R | 1 |
| Aoun, M; Ibrahim, S; Meunier, F; Tulkens, PM; Van der Auwera, P | 1 |
| Espinal, D; Garces, G; Mejia de Rodriguez, GI; Mejia, J; Restrepo, C; Restrepo, F; Robledo, C; Robledo, J; Tamayo de Guitierrez, MC; Trujillo, H | 1 |
| Craig, WA; Meunier, F; Pechère, JC | 1 |
| Havlik, I; Lipman, J; Marik, PE; Monteagudo, FS | 1 |
| Beaucaire, G; Beuscart, C; Caillaux, M; Chidiac, C; Karp, P; Leroy, O | 1 |
| Chimura, T; Funayama, T; Kanasugi, H; Miyata, R; Morisaki, N; Oono, T; Saitou, N; Sakai, Y; Satou, S; Takahashi, H | 1 |
| Hirabayashi, N; Hotta, T; Kato, Y; Kodera, Y; Mizuno, H; Morishima, Y; Morishita, Y; Saito, H; Suzuki, H; Tanaka, M | 1 |
| Jacobus, NV; Petersen, PJ; Testa, RT; Weiss, WJ | 1 |
| Baïramis, T; Davros, J; Hadzis, A; Kafetzis, DA; Papadatos, J; Papandreou, Y; Paraskaki, E; Scouroliakou, M; Sianidou, L; Vlachos, E | 1 |
| Giamarellou, H; Moschovakis, E; Petrikkos, G; Sfikakis, P; Vavouraki, E; Voutsinas, D; Yiallouros, K | 1 |
| de Pauw, BE; Donnelly, JP; Nováková, IR | 1 |
| Hirano, S; Hisazumi, H; Motoi, I; Ohkawa, M; Okasho, A | 1 |
| Pearson, RL; Perry, CR | 1 |
| Kohls, PR; Strate, RG; Zaske, DE | 1 |
| Boulis, SA; Floras, GA; Kabbani, K; Lekkas, ET; Paizis, JB; Tsimoyiannis, EC | 1 |
| Hotta, T; Kagami, Y; Mitomo, Y; Mizuno, H; Murate, T; Nitta, M; Ohnishi, K; Ohno, R; Saito, H; Yamao, H | 1 |
| Bittner, MJ; Destache, CJ; Hermann, KG; Meyer, SK | 1 |
| Amstutz, P; Blanloeil, Y; Cathala, B; Chopin, C; Gouin, F; Grimaud, D; Le Gall, JR; Rouby, JJ; Tempe, JD; Vanooteghem-Delbarre, A | 1 |
| Castro, E; McCracken, GH; Odio, CM; Salas, JL; Umaña, MA | 1 |
| Gerding, DN; Johnson, S; Lee, JT; Olson, MM; Peterson, LR | 1 |
| Grassman, R; Henning, PA; Hesseling, PB; Kirsten, GF; Mouton, WL; Schraader, EB; Spruyt, LL; Wessels, G | 1 |
| Kamnev, IuV; Kuznetsova, SM; Sokolova, VI | 1 |
| Hammerberg, O; Kurnitzki, C; Rosenbloom, D; Watts, J | 1 |
| Bertrand, H; Boulanger-Ferre, F; Descottes, B; Desport, JC; Devalois, B; Mercury, P; Peze, P; Sardin, B | 1 |
| Renneberg, J; Walder, M | 1 |
| Smolianskaia, AZ | 1 |
| Cantonetti, M; Criscuolo, D; Cudillo, L; Masi, M; Papa, G; Scimò, MT; Tribalto, M | 1 |
| Abe, T; Misawa, S; Nakagawa, H; Nishigaki, H; Okuda, T; Takino, T; Tanaka, S; Taniwaki, M; Tsuda, S | 1 |
| Avril, JL; Betremieux, P; Deramoudt-Dutrus, V; Le Marec, B; Lefrançois, C; Malledant, Y | 1 |
| Ramirez-Ronda, CH; Rivera-Vazquez, CR; Rodriguez, JR; Saavedra, S | 1 |
| Arnow, P; Edlin, B; Flaherty, JP; George, D; O'Keefe, P; Waitley, D; Weinstein, RA | 1 |
| Benn, R; Benson, W; Date, L; Gibson, J; Iland, H; Joshua, DE; Kronenberg, H; Vincent, PC; Wilson, A; Young, GA | 1 |
| Benedetti, M; Gasparini, G; Talamini, R; Toffoli, G; Tumolo, S; Vaglia, A | 1 |
| Casner, P; Dillon, KR; Dougherty, SH; Polly, S | 1 |
| Angelini, A; Betti, S; D'Antonio, D; Dell'Isola, M; di Girolamo, A; Dragani, A; Fioritoni, G; Iacone, A; Piccolomini, R | 1 |
| Lichtman, AR; Ludik, P | 1 |
| Agaliotis, D; Ezzeddine, H; Gala, JL; Gigi, J; Michaux, JL; Vandercam, B; Wauters, G | 1 |
| Inderlied, CB; Lancero, MG; Young, LS | 1 |
| Ericsson, CD; Fischer, RP; Hunt, C; Miller-Crotchett, P; Reed, L; Rowlands, BJ | 1 |
| Brice, P; Calvo, F; de Castro, H | 1 |
| Beuscart, C; Drugeon, H; Leroy, O; Mouton, Y; Pappo, M | 1 |
| Brion, JP; Bru, JP; Corron, B; Fauconnier, J; Michallet, M | 1 |
| Ajchenbaum, F; Baume, D; Chiche, D; Delmer, A; Fitoussi, F; Marie, JP; Pico, JL; Richet, H; Rio, B; Tancrède, C | 1 |
| Ramírez-Ronda, CH; Saavedra, S; Vera, D | 1 |
| Baker, DK; Blankenship, KR; Feldman, S; Gigliotti, F; Hughes, WT; Meyer, WH; Roberson, PK; Santana, VM; Shenep, JL; Sixbey, JW | 1 |
| Artino, RM; Dotti, G; Giacchino, M; Grazia, G; Madon, E; Mattirolo, F; Miniero, R; Vivalda, M | 1 |
| Avvisati, G; Fenu, S; Girmena, C; Martino, P; Micozzi, A; Raccah, R; Santilli, S | 1 |
| Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC | 1 |
| Bobadilla, M; Calva, JJ; Huazano, F; Ojeda, F; Ontiveros, C; Ponce de Leon, S; Ruiz-Palacios, GM; Sifuentes, J | 1 |
| Boelaert, J; Glibert, B; Gordts, B; Van Landuyt, HW; Verbruggen, AM | 1 |
| Hara, K; Hayashi, T; Masuyama, Y; Oda, T; Saito, A; Shigeno, Y; Taira, K; Tomita, H; Yamaguchi, K | 1 |
| Auzepy, P; Pezzano, M; Richard, C; Singlas, E; Sultan, E | 1 |
| Isaksson, B; Maller, R; Nilsson, L; Sörén, L | 1 |
| Guenin, K; Herschkowtiz, N; Schaad, UB; Steffen, C | 1 |
| Colucci, A; Coniglio, M; Girardi, F; Guarini, A; Iaculli, L; Liso, V; Pavone, V; Specchia, G | 1 |
| Adelman, RD; Rubio, T; Wirth, F | 1 |
| Almela, M; Carreras, E; Grañena, A; Jiménez de Anta, MT; Marín, P; Rozman, C; Valls, A | 1 |
| Ameglio, F; Casali, A; Gallo Curcio, C; Gionfra, T; Paoletti, G; Tonachella, R | 1 |
| Andrien, F; Anniko, M; Baudrihaye, M; Bow, E; Burman, LA; Louie, T; Norberg, B; Norrby, SR; Runde, V; Vandercam, B | 1 |
| Croydon, E; Weerts, D | 1 |
| Ahlborn, TN; Benvenisty, AI; Fox, CL; Modak, S; Nowygrod, R; Reemtsma, K; Sampath, L; Tannenbaum, G | 1 |
| Blaysat, G; Gardembas-Pain, M; Lemeland, JF; Tron, P; Vannier, JP | 1 |
| Hattori, M; Kaneko, Y; Kumai, R; Maseki, N; Sakurai, M; Sampi, K | 2 |
| Fasching, CE; Gerding, DN; Peterson, LR | 1 |
| Alexopoulos, E; Anassis, P; Hadjidimitriou, C; Papadimitriou, M | 1 |
| De Jongh, CA; Drusano, GL; Finley, RS; Joshi, JH; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Tenney, JH; Thompson, BW | 1 |
| McCracken, GH | 1 |
| Bonetti, A; Luthy, R; Siegenthaler, WE | 1 |
| Lerner, SA; Matz, GJ; Schmitt, BA; Seligsohn, R | 1 |
| Lietman, PS; Moore, RD; Smith, CR | 1 |
| Benedetti, M; Canobbio, L; Fassio, T; Figoli, F; Galligioni, E; Gasparini, G; Talamini, R; Toffoli, G; Tumolo, S | 1 |
| Pincus, PH; Powell, KR | 1 |
| Hoshino, K; Hotta, Y; Kawakami, K; Kita, K; Kobayashi, T; Mori, M; Nosaka, T; Ohta, C; Uchiyama, S; Uno, N | 1 |
| Calandra, T; Casey, PA; Glauser, MP; Meylan, PR | 1 |
| Klastersky, J; Lagast, H; Meunier, F; Snoeck, R; Woussen, F | 1 |
| Bru, JP; Hollard, D; Leautet, JB; Legrand, C; Michallet, M; Micoud, M; Sotto, JJ; Stahl, JP; Swierz, P | 1 |
| Antonioni, M; De Cristofaro, A; Mergoni, M; Stocchetti, N; Zuccoli, P | 1 |
| Edson, RS; Terrell, CL | 1 |
| Fujii, R; Hashira, S; Koike, Y | 1 |
| Chikaoka, H; Hirama, Y; Iwasaki, A; Masumi, R; Nakazawa, S; Narita, A; Niino, K; Sato, H; Tazoe, K | 1 |
| Nishimura, T; Tabuki, K; Takashima, T | 1 |
| Katosova, LK; Nekhorosheva, AG; Skala, LZ; Sotnikova, GD; Volkov, IK | 1 |
| Holloway, WJ | 1 |
| Blaser, J; Dudley, M; Zinner, SH | 1 |
| Chadwick, EG; Shulman, ST; Yogev, R | 1 |
| Beals, JD; Gilbert, VE; Natelson, SE; Tyler, WA | 1 |
| D'Amico, DJ; Kenyon, KR; Talamo, JH | 1 |
| Cano, JP; Charbit-Bues, M; Coignet, J; Palix, C | 1 |
| Besse, MD; Crépy, A; Galizia, JP; Goldstein, P; Marson, JC; Pellerin, P | 1 |
| Kai, F; Kurebe, M; Mitsuhashi, S; Niizato, T; Okamoto, R; Yokota, M; Yoshida, T | 1 |
| Zinner, SH | 1 |
| Dougherty, SH | 1 |
| Lewandowski, A; Orłowski, T | 1 |
| Borges, LF; Chapman, PH | 1 |
| Hanna, BA; Leibowitz, RE; Levine, JF; Maslow, MJ; Pollock, AA; Rahal, JJ; Schaefler, S; Simberkoff, MS | 1 |
| Colding, H | 1 |
| Clarridge, JE; Koza, MA; Sewell, CM; Young, EJ | 1 |
| Du, JZ; Jiang, YF; Liu, YH; Luo, MY; Qiu, ZD; Sheng, JQ; Wang, QN | 1 |
| Hull, JH; Rogers, JF; Sarubbi, FA; Wargin, WA; Williams, PJ | 1 |
| Alvarez, S; Berk, SL; Holtsclaw-Berk, SA; Ortega, G; Verghese, A | 1 |
| George, WJ; Insler, MS; Johnson, AP; LaCorte, WS; Woo, FL | 1 |
| Mordenti, JJ; Nightingale, CH; Quintiliani, R | 1 |
| Hattori, M; Kaneko, Y; Kumai, R; Sakurai, M; Sampi, K | 1 |
| Shulman, ST; Yogev, R | 1 |
| Asada, H; Ito, A; Maruta, I; Matsuzaki, M; Ogawa, K | 1 |
| Kuznetsova, SM; Lobuseva, AN; Samoĭlova, LN | 1 |
21 review(s) available for amikacin and Bacterial Disease
| Article | Year |
|---|---|
Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Division; Cytoskeletal Proteins | 2015 |
Antimicrobial treatment of urinary tract infections in children.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Child; Escherichia coli; Humans; Infant, Newborn; Urinary Tract Infections | 2023 |
A Status Update on Pharmaceutical Analytical Methods of Aminoglycoside Antibiotic: Amikacin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Humans; Pharmaceutical Preparations | 2022 |
Antibiotics for neonates born through meconium-stained amniotic fluid.
Topics: Amikacin; Amniotic Fluid; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Gentamicins; Humans; Incidence; Infant, Newborn; Length of Stay; Meconium; Meconium Aspiration Syndrome; Neonatal Sepsis; Randomized Controlled Trials as Topic; Respiration, Artificial; Respiratory Insufficiency | 2017 |
Amikacin: Uses, Resistance, and Prospects for Inhibition.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Genes, Bacterial; Gram-Negative Bacteria; Humans; Kanamycin Resistance | 2017 |
Comparative clinical trials in treatment of intra-abdominal sepsis.
Topics: Abdomen; Abdominal Injuries; Abscess; Amikacin; Animals; Bacterial Infections; Carbenicillin; Cefamandole; Cefoxitin; Chloramphenicol; Clindamycin; Clinical Trials as Topic; Humans; Metronidazole; Rats; Ticarcillin | 1981 |
Febrile neutropenia.
Topics: Amikacin; Amphotericin B; Bacteremia; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Mycoses; Neoplasms; Neutropenia; Vancomycin; Virus Diseases | 1993 |
Infectious complications in bone marrow transplantation. Resistant bacterial infections.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Humans; Lactams; Vancomycin | 1993 |
Amikacin. A new aminoglycoside antibiotic.
Topics: Amikacin; Bacterial Infections; Dose-Response Relationship, Drug; Half-Life; Humans | 1978 |
Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Interactions; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Streptomycin; Tobramycin | 1977 |
[Recent views concerning urinary tract infections].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Sulfonamides; Urinary Tract Infections | 1978 |
Netilmicin: a review of toxicity in laboratory animals.
Topics: Abnormalities, Drug-Induced; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Cochlea; Gentamicins; Glomerular Filtration Rate; Hair Cells, Auditory; Hearing; Humans; Kidney; Netilmicin; Reproduction | 1978 |
Gentamicin in 1978.
Topics: Amikacin; Animals; Bacterial Infections; Drug Synergism; Ear Diseases; Gentamicins; Humans; Kidney; Kidney Diseases; Netilmicin; Penicillin Resistance; Penicillins; Respiratory Tract Infections; Sisomicin; Tobramycin; Urinary Tract Infections | 1978 |
[Antibiotic-induced diseases. Aminoglycoside-induced renal lesions].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Kanamycin; Kidney Diseases; Kidney Function Tests; Sisomicin; Streptomycin; Tobramycin | 1978 |
Empiric therapy of febrile granulocytopenic patients.
Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Cephalosporins; Drug Therapy, Combination; Gentamicins; Granulocytes; Humans; Klebsiella Infections; Neoplasms; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Tobramycin | 1979 |
Recent advances in antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Flucytosine; Gentamicins; Metronidazole; Penicillins; Plasmids; Sisomicin; Tobramycin | 1976 |
[Comparative study of the administration of amikacin by intramuscular and intravenous routes in neonatal resuscitation].
Topics: Amikacin; Bacterial Infections; Ear; Humans; Infant, Newborn; Injections, Intramuscular; Injections, Intravenous; Intensive Care Units, Neonatal; Kidney; Prospective Studies | 1989 |
Aminoglycoside toxicity in infants and children.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Child; Clinical Trials as Topic; Evoked Potentials, Auditory; Gentamicins; Hearing; Humans; Infant; Infant, Newborn; Kanamycin; Kidney; Prospective Studies; Risk; Streptomycin; Tobramycin; Vestibule, Labyrinth | 1986 |
Aminoglycoside antibiotics in infectious diseases. An overview.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Kanamycin; Kinetics; Neomycin; Netilmicin; Pneumonia; Sepsis; Sisomicin; Streptomycin; Tobramycin | 1986 |
Role of amikacin in the management of intra-abdominal sepsis.
Topics: Abdomen; Abscess; Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Kanamycin; Lactams; Peritonitis; Wound Infection | 1985 |
Shunt infections: prevention and treatment.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cerebrospinal Fluid Shunts; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Humans; Injections, Intravenous; Injections, Intraventricular; Klebsiella Infections; Leukocytes; Meningitis; Premedication; Pseudomonas Infections; Reoperation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin | 1985 |
132 trial(s) available for amikacin and Bacterial Disease
| Article | Year |
|---|---|
Comparison of two empiric antibiotic regimen in late onset neonatal sepsis--a randomized controlled trial.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cloxacillin; Drug Therapy, Combination; Female; Follow-Up Studies; Gentamicins; Hospitals, Teaching; Humans; India; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Length of Stay; Male; Outcome Assessment, Health Care; Sepsis; Single-Blind Method; Time Factors | 2014 |
Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: a randomized controlled trial.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; India; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Sepsis; Treatment Outcome | 2014 |
A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Ceftriaxone; Ciprofloxacin; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Fever; Greece; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome | 2008 |
Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Male; Neutropenia; Treatment Outcome; Young Adult | 2009 |
Impact of infusion method on amikacin serum levels in humans.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Community-Acquired Infections; Female; Half-Life; Humans; Infusion Pumps; Infusions, Intravenous; Lung Diseases; Male; Middle Aged; Time Factors; Tissue Distribution | 2010 |
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult | 2010 |
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin | 2003 |
Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma.
Topics: Adolescent; Amikacin; Bacterial Infections; Brazil; Ceftriaxone; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Epidemiologic Methods; Female; Fever; Humans; Infant; Leukemia; Lymphoma, Non-Hodgkin; Male; Neutropenia; Ticarcillin; Treatment Outcome | 2003 |
[Cefepime/amikacin in the empirical antibacterial therapy for patients with hemoblastosis of different forms].
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Hematologic Neoplasms; Humans; Leukocyte Count; Neutropenia; Neutrophils; Time Factors; Treatment Outcome | 2003 |
[Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Treatment Outcome | 2003 |
Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life.
Topics: Amikacin; Bacterial Infections; Double-Blind Method; Gestational Age; Half-Life; Humans; Ibuprofen; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infusions, Intravenous; Lysine; Metabolic Clearance Rate; Placebos; Retrospective Studies | 2004 |
Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Humans; Liver Cirrhosis; Peritonitis; Retrospective Studies; Treatment Outcome | 2005 |
Implementation and evaluation of a once-daily amikacin dosing protocol in a long-term care facility.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; C-Reactive Protein; Creatinine; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Health Facilities; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney Function Tests; Leukocyte Count; Long-Term Care; Male; Respiratory Tract Infections; Treatment Outcome | 2007 |
Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2008 |
Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
Topics: Abdomen; Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Ceftazidime; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Humans; India; Male; Metronidazole; Middle Aged; Sulbactam; Treatment Outcome | 2008 |
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2008 |
[Antibiotic therapy of infections in cancer patients with leukopenia].
Topics: Amikacin; Bacterial Infections; gamma-Globulins; Humans; Kanamycin; Leukemia; Leukopenia; Lymphoma; Penicillin G; Sulbenicillin | 1983 |
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cephalosporins; Cephamycins; Child; Double-Blind Method; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Kanamycin; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Prospective Studies; Random Allocation; Ticarcillin | 1982 |
Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Carbenicillin; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Male; Middle Aged; Penicillins; Piperacillin; Prospective Studies | 1982 |
[Role of azlocillin in the treatment of immunocompromised patients. Results of the EORTC (European Organization for Research on the Treatment of Cancer) study)].
Topics: Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neoplasms; Penicillins; Ticarcillin | 1984 |
Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. A report of the EORTC International Antimicrobial Therapy Project Group.
Topics: Administration, Oral; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Carbenicillin; Cefazolin; Clinical Trials as Topic; Drug Therapy, Combination; Granulocytes; Humans | 1983 |
Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Carbenicillin; Cefazolin; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Kanamycin; Kidney Diseases; Neoplasms; Neutropenia | 1983 |
Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Leukemia; Male; Middle Aged; Neoplasms; Penicillins; Piperacillin; Prospective Studies; Random Allocation; Ticarcillin | 1981 |
A prospective, randomized study of amikacin and gentamicin in serious infections with focus on efficacy, toxicity and duration of serum levels above the MIC.
Topics: Adolescent; Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Ear; Female; Gentamicins; Humans; Kanamycin; Kidney; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Random Allocation | 1983 |
Combination of amikacin and either ampicillin or cephalotin as initial treatment of febrile neutropenic patients.
Topics: Adult; Aged; Agranulocytosis; Amikacin; Ampicillin; Bacterial Infections; Cephalothin; Clinical Trials as Topic; Drug Combinations; Female; Fever; Hematologic Diseases; Humans; Kanamycin; Male; Middle Aged; Neutropenia; Prospective Studies; Random Allocation | 1982 |
A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Gentamicins; Humans; Netilmicin; Prospective Studies; Tobramycin | 1982 |
Short-course aminoglycoside therapy in patients with spinal cord injury. Standard dose versus low dose.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Humans; Injections, Intramuscular; Kanamycin; Proteus Infections; Providencia; Pseudomonas Infections; Random Allocation; Recurrence; Spinal Cord Injuries; Tobramycin; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1980 |
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fever; Hearing Loss; Humans; Kanamycin; Kidney; Kinetics; Moxalactam; Neoplasms; Piperacillin; Ticarcillin | 1982 |
Ocular penetration of amikacin following intramuscular injection.
Topics: Adult; Aged; Amikacin; Aqueous Humor; Bacterial Infections; Eye; Eye Diseases; Female; Humans; Injections, Intramuscular; Kanamycin; Male; Middle Aged | 1983 |
Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Gentamicins; Humans; Kanamycin; Lung Diseases; Male; Middle Aged; Netilmicin; Sepsis; Urinary Tract Infections | 1980 |
Prospective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity.
Topics: Aged; Amikacin; Audiometry, Pure-Tone; Bacterial Infections; Caloric Tests; Clinical Trials as Topic; Creatinine; Female; Gentamicins; Hearing; Humans; Kanamycin; Kidney; Male; Middle Aged; Netilmicin; Random Allocation; Sex Factors; Vestibule, Labyrinth; Vestibulocochlear Nerve | 1980 |
A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cefoxitin; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Kanamycin; Male; Middle Aged; Postoperative Complications; Prospective Studies | 1981 |
Comparative clinical trials in treatment of intra-abdominal sepsis.
Topics: Abdomen; Abdominal Injuries; Abscess; Amikacin; Animals; Bacterial Infections; Carbenicillin; Cefamandole; Cefoxitin; Chloramphenicol; Clindamycin; Clinical Trials as Topic; Humans; Metronidazole; Rats; Ticarcillin | 1981 |
[Infections in leukemia and malignant lymphoma. Comparison between 2 antibiotic regimens: amikacin or gentamicin in combination with cephalothin].
Topics: Amikacin; Bacterial Infections; Cephalothin; Drug Therapy, Combination; Gentamicins; Humans; Leukemia; Lymphoma | 1981 |
Cost comparison of two antimicrobial regimens for treating mixed aerobic-anaerobic infections.
Topics: Aerobiosis; Amikacin; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Cefoxitin; Clindamycin; Costs and Cost Analysis; Gentamicins; Humans; Tobramycin | 1981 |
Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infections.
Topics: Abdomen; Abscess; Adult; Amikacin; Appendicitis; Aztreonam; Bacterial Infections; Clindamycin; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intestinal Perforation; Male; Prospective Studies; Single-Blind Method | 1994 |
Once daily antibiotic regimen in paediatric oncology.
Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Ceftriaxone; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Humans; Infant; Neoplasms; Teicoplanin; Vancomycin | 1994 |
Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors.
Topics: Adult; Amikacin; Antifungal Agents; Bacterial Infections; Cause of Death; Ceftazidime; Drug Combinations; Female; Humans; Length of Stay; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Neutropenia; Pneumonia; Prognosis; Prospective Studies; Remission Induction; Time Factors; Treatment Outcome | 1994 |
A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Bacterial Infections; Cefepime; Cephalosporins; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Respiratory Tract Infections; Shock, Septic | 1993 |
[Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Sulbactam | 1993 |
Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Vancomycin | 1993 |
Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of the Eu
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Ceftriaxone; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ear Diseases; Female; Humans; Infant, Newborn; Infections; Kidney Diseases; Male; Middle Aged; Neoplasms; Prospective Studies; Treatment Outcome | 1993 |
Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacteremia; Bacteria; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Teicoplanin | 1993 |
Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbapenems; Ceftazidime; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Respiratory Tract Infections; Sepsis; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections | 1995 |
Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Drug Tolerance; Humans; Infant; Meropenem; Metronidazole; Thienamycins | 1995 |
A randomised comparison of isepamicin and amikacin in the treatment of bacterial infections in paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Staphylococcal Infections; Staphylococcus epidermidis; Streptococcal Infections | 1995 |
Population pharmacokinetics of amikacin in critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Body Fluid Compartments; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Male; Middle Aged; Predictive Value of Tests | 1996 |
Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis.
Topics: Acute Disease; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Female; Humans; Male; Metronidazole; Middle Aged; Pancreatitis, Alcoholic | 1996 |
Amikacin as first-choice aminoglycoside in a medical intensive care unit: a one-year bacteriological surveillance study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Belgium; Child; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies | 1996 |
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gastrointestinal Diseases; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Male; Neutropenia; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections | 1997 |
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins | 1998 |
[Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Treatment Outcome | 1998 |
Percutaneous suprapubic transvesical route: a new and comfortable method of intraprostatic injection.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Chronic Disease; Humans; Injections; Male; Middle Aged; Prostate; Prostatitis; Recurrence; Treatment Failure | 1998 |
Prospective randomized study of once-daily versus twice-daily amikacin regimens in patients with systemic infections.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Female; Hearing Disorders; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies | 1998 |
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin | 1999 |
An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia.
Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Child; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 1999 |
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia, Bacterial; Sepsis | 2000 |
[Combination therapy of antibiotics and intravenous immunoglobulin].
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Drug Therapy, Combination; Humans; Imipenem; Immunoglobulins, Intravenous; Multicenter Studies as Topic; Protease Inhibitors; Randomized Controlled Trials as Topic; Thienamycins | 2001 |
[Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Treatment Outcome | 2001 |
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2001 |
Comparison of isepamicin with amikacin for the empirical treatment of febrile neutropenic children with malignancies.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Fever; Gentamicins; Humans; Male; Neoplasms; Neutropenia; Random Allocation | 2001 |
Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation.
Topics: Age Factors; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Body Weight; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Kidney; Metabolic Clearance Rate; Models, Biological; Statistics, Nonparametric | 2001 |
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Controlled comparison of amikacin and gentamicin.
Topics: Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Clinical Trials as Topic; Drug Evaluation; Drug Resistance, Microbial; Gentamicins; Hearing Disorders; Humans; Kanamycin; Kidney; Middle Aged; Prospective Studies; Sepsis; Urinary Tract Infections | 1977 |
Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Gentamicins; Humans; Infections; Kanamycin; Male; Middle Aged; Neoplasms; Penicillin Resistance; Penicillins; Sepsis; Ticarcillin | 1979 |
Empirical therapy in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Carbenicillin; Cephalothin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Gentamicins; Granulocytes; Humans; Male; Middle Aged; Neoplasms; Transplantation, Homologous | 1979 |
A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbenicillin; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Parenteral; Kanamycin; Kidney; Male; Middle Aged; Neoplasms; Neutropenia; Uremia | 1979 |
Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail.
Topics: Adult; Amikacin; Bacterial Infections; Carbenicillin; Drug Synergism; Gentamicins; Hearing Disorders; Humans; Kanamycin; Kidney Diseases; Leukopenia; Penicillin Resistance; Sepsis | 1977 |
Evaluation of three antibiotic programs in newborn infants.
Topics: Amikacin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bilirubin; Cephalothin; Drug Therapy, Combination; Evaluation Studies as Topic; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Pneumonia; Sepsis; Tobramycin | 1978 |
Clinical and bacteriological evaluation of amikacin in severe gram-negative infections.
Topics: Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Clinical Trials as Topic; Female; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged | 1976 |
Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial.
Topics: Amikacin; Bacterial Infections; Blood Bactericidal Activity; Carbenicillin; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Kanamycin; Penicillin G; Pseudomonas Infections; Sepsis | 1976 |
A review of results of clinical trials with amikacin.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Bone Diseases; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Kanamycin; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1976 |
Randomized comparison of ceftriaxone versus ceftriaxone plus amikacin for the empirical treatment of infections in patients with altered host defense: microbiological and clinical evaluation.
Topics: Adult; Amikacin; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Male | 1992 |
Amikacin once daily plus metronidazole versus amikacin twice daily plus metronidazole in colorectal surgery.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Colon; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Postoperative Complications; Prospective Studies; Rectum | 1992 |
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Vancomycin | 1992 |
[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Ticarcillin; Vancomycin | 1992 |
[Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Piperacillin; Prospective Studies | 1992 |
Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Pneumocystis Infections; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prognosis; Superinfection | 1992 |
Ceftriaxone and amikacin versus ceftazidime and amikacin in febrile granulocytopenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neoplasms | 1991 |
Randomized clinical trial comparing ceftriaxone/amikacin versus ceftazidime/amikacin as initial therapy of febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftazidime; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neutropenia | 1991 |
A comparative study on aztreonam, ceftazidime and amikacin in the treatment of complicated urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aztreonam; Bacterial Infections; Ceftazidime; Female; Humans; Male; Middle Aged; Prospective Studies; Urinary Tract Infections | 1991 |
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Lymphoma; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies | 1991 |
Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Scandinavian Amikacin Once Daily Study Group.
Topics: Adult; Aged; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hearing; Humans; Male; Middle Aged; Penicillins; Piperacillin | 1991 |
The pharmacokinetic of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Child; Child, Preschool; Creatinine; Drug Administration Schedule; Female; Gram-Negative Aerobic Bacteria; Humans; Infant; Kidney; Male; Microbial Sensitivity Tests; Middle Aged | 1991 |
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Middle Aged; Ofloxacin; Piperacillin; Prospective Studies | 1991 |
[Clinical effect of the combined use of aztreonam, amikacin and clindamycin in infectious disease in obstetrics and gynecology].
Topics: Adult; Aged; Amikacin; Aztreonam; Bacterial Infections; Clindamycin; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Japan; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies | 1991 |
[Laboratory and clinical studies on imipenem/cilastatin sodium plus amikacin sulfate in patients with severe infections complicating hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Cilastatin; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; In Vitro Techniques; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged | 1991 |
Clinical and pharmacokinetic study of a single daily dose of amikacin in paediatric patients with severe gram-negative infections.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Hearing; Humans; Infant; Kidney; Lactams; Male; Pseudomonas aeruginosa | 1991 |
Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Drug Administration Schedule; Enterobacteriaceae; Female; Gram-Negative Bacteria; Hearing; Humans; Kidney; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Respiratory Tract Infections; Serum Bactericidal Test; Urinary Tract Infections | 1991 |
Ceftazidime with or without amikacin for the empiric treatment of localized infections in febrile, granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Prospective Studies | 1991 |
Short-term antibiotic prophylaxis in elective colorectal surgery.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Colorectal Neoplasms; Costs and Cost Analysis; Female; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Ornidazole; Premedication; Prospective Studies | 1991 |
Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer In
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Gram-Positive Bacteria; Humans; Infant; Male; Middle Aged; Neoplasms; Prospective Studies; Sepsis; Vancomycin | 1991 |
[Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cephamycins; Clindamycin; Drug Therapy, Combination; Female; Fosfomycin; Hematologic Diseases; Humans; Male | 1990 |
Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides: a cost-benefit analysis.
Topics: Amikacin; Aminoglycosides; Bacterial Infections; Cost-Benefit Analysis; Female; Gentamicins; Gram-Negative Bacteria; Humans; Length of Stay; Male; Monitoring, Physiologic; Prospective Studies; Tobramycin | 1990 |
Gram-positive bacteraemia in granulocytopenic cancer patients.
Topics: Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Sepsis | 1990 |
Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections.
Topics: Amikacin; Ampicillin; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Infant, Newborn; Male; Prospective Studies; Randomized Controlled Trials as Topic; Superinfection | 1990 |
Clostridium difficile diarrhea and colonization after treatment with abdominal infection regimens containing clindamycin or metronidazole.
Topics: Abdomen; Amikacin; Ampicillin; Bacterial Infections; Clindamycin; Clostridium; Clostridium Infections; Diarrhea; Double-Blind Method; Feces; Humans; Metronidazole; Placebos; Prospective Studies; Random Allocation | 1990 |
Randomized trial using piperacillin versus ampicillin and amikacin for treatment of premature neonates with risk factors for sepsis.
Topics: Amikacin; Ampicillin; Bacterial Infections; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant, Newborn; Infant, Premature, Diseases; Piperacillin; Random Allocation; Risk Factors; Sepsis | 1989 |
A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aztreonam; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Male; Mezlocillin; Middle Aged; Pneumonia; Random Allocation; Tobramycin | 1989 |
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Random Allocation | 1989 |
A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Floxacillin; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Randomized Controlled Trials as Topic; Remission Induction; Therapeutic Equivalency | 1989 |
Individualized pharmacokinetic versus standard dosing of amikacin: a comparison of therapeutic outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Drug Resistance, Microbial; Female; Humans; Kidney Diseases; Male; Middle Aged; Randomized Controlled Trials as Topic | 1989 |
Evaluation of azlocillin-amikacin combination for empirical therapy of infection in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neutropenia | 1989 |
Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Female; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Random Allocation | 1989 |
Prophylactic antibiotics in trauma: the hazards of underdosing.
Topics: Abdominal Injuries; Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Clindamycin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injury Severity Score; Male; Middle Aged; Postoperative Complications; Premedication; Random Allocation | 1989 |
[Treatment of infectious outbreaks in neutropenic patients with a piperacillin and amikacin combination].
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neutropenia; Pilot Projects; Piperacillin | 1986 |
[Controlled randomized prospective study of a ceftazidime-pefloxacin combination versus a ceftazidime-amikacin combination in the empirical treatment of nosocomial pneumonias and septicemias of resuscitation. Preliminary results].
Topics: Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation | 1988 |
[Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillins; Prospective Studies; Ticarcillin; Vancomycin | 1988 |
[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Neutropenia; Random Allocation; Vancomycin | 1988 |
Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Bacterial Infections; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillins; Random Allocation; Ticarcillin; Vancomycin | 1988 |
Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Piperacillin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Random Allocation | 1988 |
[Comparative clinical trial of HBK and amikacin (AMK) in the treatment of respiratory infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Dibekacin; Double-Blind Method; Female; Humans; Kanamycin; Male; Middle Aged; Respiratory Tract Infections | 1987 |
A study of amikacin given once versus twice daily in serious infections.
Topics: Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Drug Administration Schedule; Humans; Kidney; Middle Aged; Prospective Studies; Random Allocation | 1988 |
Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies | 1988 |
A controlled study of the nephrotoxicity of mezlocillin and amikacin in the neonate.
Topics: Amikacin; Bacterial Infections; Clinical Trials as Topic; Female; Humans; Infant, Newborn; Kidney; Male; Mezlocillin; Random Allocation | 1987 |
Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
Topics: Adult; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Piperacillin; Random Allocation | 1987 |
Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillin Resistance; Piperacillin; Prospective Studies; Random Allocation; Thienamycins | 1987 |
European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
Topics: Adult; Agranulocytosis; Amikacin; Bacterial Infections; beta-Lactamase Inhibitors; Child; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Netilmicin; Neutropenia; Penicillins; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin | 1987 |
[Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cefmenoxime; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies; Random Allocation | 1987 |
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blood Bactericidal Activity; Blood Coagulation Disorders; Clinical Trials as Topic; Drug Hypersensitivity; Drug Synergism; Drug Therapy, Combination; Fever; Hearing Disorders; Humans; Infections; Kanamycin; Kidney Diseases; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation | 1986 |
Aminoglycoside toxicity in infants and children.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Child; Clinical Trials as Topic; Evoked Potentials, Auditory; Gentamicins; Hearing; Humans; Infant; Infant, Newborn; Kanamycin; Kidney; Prospective Studies; Risk; Streptomycin; Tobramycin; Vestibule, Labyrinth | 1986 |
Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin.
Topics: Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Female; Gentamicins; Hearing; Humans; Kanamycin; Kidney; Male; Middle Aged; Prospective Studies; Random Allocation | 1986 |
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Female; Gentamicins; Gram-Negative Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Random Allocation; Tobramycin | 1987 |
Combination of amikacin and ceftazidime as empiric treatment of febrile leukopenic patients affected by solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Immune Tolerance; Leukopenia; Middle Aged; Neoplasms | 1987 |
A prospective randomized study comparing the efficacy of Timentin alone or in combination with amikacin in the treatment of febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Clavulanic Acids; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Male; Middle Aged; Penicillin Resistance; Penicillins; Prospective Studies; Random Allocation; Sepsis; Ticarcillin | 1986 |
Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients.
Topics: Adult; Aged; Amikacin; Azlocillin; Bacterial Infections; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Random Allocation | 1987 |
Review of amikacin usage in the EORTC trials.
Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Gentamicins; Humans; International Cooperation; Kanamycin; Kidney Diseases; Lactams; Neoplasms; Neutropenia | 1985 |
[Use of amikacin in surgical wound infections].
Topics: Amikacin; Bacterial Infections; Clinical Trials as Topic; Humans; Kanamycin; Surgical Wound Infection | 1985 |
Antibiotic resistance patterns during aminoglycoside restriction.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Pseudomonas aeruginosa; Time Factors | 1985 |
Laboratory and clinical studies on amikacin.
Topics: Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Kanamycin; Pyelonephritis; Sepsis; Staphylococcus aureus | 1985 |
241 other study(ies) available for amikacin and Bacterial Disease
| Article | Year |
|---|---|
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Gentamicins; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Phosphotransferases (Alcohol Group Acceptor); Recombinant Proteins | 2008 |
Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antimicrobial Cationic Peptides; Bacterial Infections; Biofilms; Cathelicidins; Cattle; Cells, Cultured; Dexamethasone; Drug Design; Humans; In Vitro Techniques; Interleukins; Macrophages; Microbial Sensitivity Tests; Neutrophils; Phagocytosis; Pseudomonas aeruginosa; Receptors, Glucocorticoid; Spermine; Staphylococcus aureus | 2010 |
Synthesis and antimicrobial activities of novel 1H-dibenzo[a,c]carbazoles from dehydroabietic acid.
Topics: Abietanes; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Carbazoles; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Spectrum Analysis; Structure-Activity Relationship | 2010 |
New heterocyclic compounds from 1,2,4-triazole and 1,3,4-thiadiazole class bearing diphenylsulfone moieties. Synthesis, characterization and antimicrobial activity evaluation.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Thiadiazoles; Triazoles | 2012 |
Synthesis, antibacterial and cytotoxic activities of new biflorin-based hydrazones and oximes.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Bacteria; Bacterial Infections; Cell Line, Tumor; Humans; Hydrazones; Microbial Sensitivity Tests; Naphthoquinones; Neoplasms; Oximes; Scrophulariaceae | 2016 |
Bis(N-amidinohydrazones) and N-(amidino)-N'-aryl-bishydrazones: New classes of antibacterial/antifungal agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Cell Line; Drug Discovery; Drug Resistance, Multiple; Fungi; Humans; Hydrazones; Microbial Sensitivity Tests; Mycoses | 2017 |
Bacterial profile of diabetic foot infections and antibiotic susceptibility in a specialized diabetes centre in Cameroon.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cameroon; Communicable Diseases; Diabetes Mellitus, Type 2; Diabetic Foot; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2022 |
Amikacin-loaded niosome nanoparticles improve amikacin activity against antibiotic-resistant Klebsiella pneumoniae strains.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cholesterol; COVID-19; Humans; Klebsiella pneumoniae; Lipids; Liposomes; Microbial Sensitivity Tests; Nanoparticles; Polysorbates; RNA, Messenger; SARS-CoV-2; Surface-Active Agents | 2022 |
Amikacin@SiO
Topics: Amikacin; Bacterial Infections; Humans; Nanoparticles; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared | 2023 |
In vitro and in vivo antimicrobial activity of sodium colistimethate and amikacin-loaded nanostructured lipid carriers (NLC).
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Colistin; Drug Carriers; Drug Resistance, Bacterial; Humans; Lipids; Nanostructures; Pseudomonas aeruginosa | 2020 |
Amikacin and bacteriophage treatment modulates outer membrane proteins composition in Proteus mirabilis biofilm.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bacterial Outer Membrane Proteins; Bacteriophages; Biofilms; Drug Resistance, Microbial; Gram-Negative Bacteria; Membrane Proteins; Proteus mirabilis | 2021 |
Amikacin-containing self-emulsifying delivery systems via pulmonary administration for treatment of bacterial infections of cystic fibrosis patients.
Topics: Amikacin; Bacterial Infections; Cystic Fibrosis; Drug Delivery Systems; Drug Liberation; Emulsions; Humans; Hydrophobic and Hydrophilic Interactions; Lipids; Mucus; Permeability; Pseudomonas aeruginosa; Respiratory Therapy | 2018 |
Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Bacterial Infections; beta-Lactamases; Biopsy; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Male; Middle Aged; Odds Ratio; Prostate; Rectum; Retrospective Studies; Risk Factors; Ultrasonography, Interventional | 2018 |
Urinary tract infections in patients with orthotopic neobladder.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cohort Studies; Cystectomy; Escherichia coli; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Patient Discharge; Postoperative Complications; Proportional Hazards Models; Pseudomonas aeruginosa; Tertiary Care Centers; Urinary Bladder; Urinary Diversion; Urinary Reservoirs, Continent; Urinary Tract Infections | 2014 |
Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cohort Studies; Critical Illness; Female; Gentamicins; Humans; Intraabdominal Infections; Male; Middle Aged; Plasma; Pneumonia, Bacterial; Urinary Tract Infections | 2015 |
Epidemiology of antimicrobial resistance in an oncology center in eastern India.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts | 2015 |
Fit-for-purpose chromatographic method for the determination of amikacin in human plasma for the dosage control of patients.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Fluorometry; Humans; Quality Control; Spectrophotometry, Ultraviolet | 2016 |
Multidrug-Resistant Pathogens in Hospitalized Syrian Children.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Armed Conflicts; Bacterial Infections; Child; Child, Preschool; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitalization; Humans; Infant; Infant, Newborn; Israel; Male; Meropenem; Multiple Trauma; Syria; Thienamycins | 2017 |
Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea.
Topics: Acute Disease; Adult; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Prostatitis; Republic of Korea; Retrospective Studies; Risk Factors | 2016 |
The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.
Topics: Adolescent; Adult; Age Factors; Amikacin; Anti-Bacterial Agents; Audiometry, Pure-Tone; Bacterial Infections; Cystic Fibrosis; Female; Hearing Loss; Humans; Male; Middle Aged; Patient Outcome Assessment; Sex Factors; Time; Tobramycin; United States; Vancomycin | 2017 |
Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006.
Topics: Adolescent; Amikacin; Ampicillin; Analysis of Variance; Antibiotic Prophylaxis; Bacterial Infections; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacterial; Female; Follow-Up Studies; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Male; Microbial Sensitivity Tests; Probability; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Turkey; Urinalysis; Urinary Tract Infections; Urine | 2009 |
Changes in the rates of antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa between 2002 and 2004 in a tertiary-care teaching hospital in Turkey.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Drug Resistance, Bacterial; Hospitals, Teaching; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Turkey | 2008 |
Switch therapy in full-term neonates with presumed or proven bacterial infection.
Topics: Administration, Oral; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Case-Control Studies; Cefpodoxime; Ceftizoxime; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infusions, Intravenous; Male; Sulbactam | 2009 |
Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.
Topics: Amikacin; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Bayes Theorem; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Hospitals, University; Humans; Intensive Care Units; Male; Middle Aged; Models, Statistical; Predictive Value of Tests; Retrospective Studies | 2009 |
Images in cardiovascular medicine. Bacterial pericarditis due to Providencia stuartii: an atypical case of relapsing pericarditis.
Topics: Amikacin; Bacterial Infections; Echocardiography; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pericarditis; Providencia; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carboplatin; Cisplatin; Cross-Sectional Studies; Female; Gentamicins; Hearing Tests; Humans; Incidence; Male; Middle Aged; Neoplasms; Prospective Studies; Risk; Time Factors; Tinnitus; Tobramycin; Vancomycin; Veterans | 2010 |
Local antibiotic delivery using tailorable chitosan sponges: the future of infection control?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Biocompatible Materials; Chitosan; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Fractures, Open; Goats; Infection Control; Pseudomonas Infections; Staphylococcal Infections; Vancomycin | 2010 |
Efficacy of intraoperative irrigation with saline for preventing shunt infection.
Topics: Amikacin; Bacterial Infections; Cerebrospinal Fluid Shunts; Child, Preschool; Female; Humans; Intraoperative Care; Male; Postoperative Complications; Sodium Chloride; Solutions; Surgical Wound Infection; Therapeutic Irrigation; Treatment Outcome | 2010 |
Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Biopsy, Needle; Chi-Square Distribution; Drug Therapy, Combination; Fluoroquinolones; Humans; Male; Middle Aged; Postoperative Complications; Prostate; Prostatic Diseases; Treatment Outcome; Urinary Tract Infections | 2011 |
Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater.
Topics: Adult; Aeromonas hydrophila; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Resistance, Bacterial; Fresh Water; Humans; Male; Microbial Sensitivity Tests; Soft Tissue Infections; Tobramycin; Wounds and Injuries | 2011 |
Therapeutic drug monitoring of aminoglycosides in acute myeloid leukaemia patients.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Gentamicins; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Practice Guidelines as Topic; Treatment Outcome; Young Adult | 2012 |
Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Monitoring; Gentamicins; Humans; Injections; Netilmicin; Tobramycin | 2012 |
Elderly haematological patients with chemotherapy-induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study of risk-adapted therapy.
Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftazidime; Cephalosporins; Chi-Square Distribution; Hematologic Neoplasms; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia; Prospective Studies; Risk Factors; Treatment Outcome | 2003 |
[Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Infant; Neoplasms; Neutropenia; Patient Selection; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome | 2003 |
[Endogenous bacterial endophthalmitis: a retrospective study on 22 consecutive cases].
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Causality; Combined Modality Therapy; Endophthalmitis; Eye Enucleation; Female; Gentamicins; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Analysis; Vancomycin; Vitrectomy; Vitreous Body | 2004 |
Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cloxacillin; Drug Resistance, Bacterial; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Hospitals, University; Humans; Imipenem; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pakistan; Retrospective Studies; Vancomycin | 2004 |
Bactericidal activity and post-antibiotic effect in vitro of dactimicin alone and in combination with other drugs.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Combinations; Humans; Microbial Sensitivity Tests | 1989 |
The antibiotic regimen for patients with suppurative peritonitis during peritoneal lavage program.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Candida; Cefmenoxime; Humans; Peritoneal Lavage; Peritonitis | 1989 |
Limited predictability of amikacin clearance in extreme premature neonates at birth.
Topics: Age Factors; Amikacin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bacterial Infections; Birth Weight; Body Size; Cyclooxygenase Inhibitors; Humans; Ibuprofen; Infant; Infant, Newborn; Infant, Premature; Retrospective Studies | 2006 |
Amikacin dosing and monitoring in spinal cord injury patients: variation in clinical practice between spinal injury units and differences in experts' recommendations.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Dosage Forms; Drug Administration Schedule; Drug Monitoring; Expert Testimony; Internationality; Practice Guidelines as Topic; Practice Patterns, Physicians'; Spinal Cord Injuries; Surveys and Questionnaires | 2006 |
Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Topics: Adolescent; Age Factors; Amikacin; Ampicillin; Antibiotic Prophylaxis; Bacterial Infections; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Female; Gentamicins; Humans; Infant; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections | 2006 |
Amikacin-loaded vascular prosthesis as an effective drug carrier.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Blood Vessel Prosthesis; Chromatography, High Pressure Liquid; Drug Carriers; Humans; Microbial Sensitivity Tests; Postoperative Complications | 2007 |
[The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods].
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Microbial Sensitivity Tests; Neomycin; Netilmicin; Phenotype; Pseudomonas aeruginosa; Tobramycin | 2006 |
Vestibular system in infants after systemic aminoglycoside therapy.
Topics: Amikacin; Aminoglycosides; Bacterial Infections; Caloric Tests; Evoked Potentials, Auditory; Evoked Potentials, Auditory, Brain Stem; Female; Humans; Infant; Injections, Intravenous; Male; Time Factors; Vestibular Diseases | 2007 |
[Serial measurement of serum levels of amikacin. Value in therapy].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Female; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Time Factors | 1981 |
[Kinetics of multiple-dose amikacin in the newborn infant].
Topics: Amikacin; Bacterial Infections; Female; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Kanamycin; Kinetics; Pregnancy | 1981 |
Treatment of severe infections in patients with cancer. The role of new acyl-penicillins.
Topics: Amikacin; Azlocillin; Bacterial Infections; Drug Therapy, Combination; Humans; Mezlocillin; Neoplasms; Penicillins; Piperacillin | 1982 |
Cefotaxime and amikacin: results of in vitro and in vivo studies against Gram-negative bacteria and Staphylococcus aureus. EORTC International Antimicrobial Therapy Project Group.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Synergism; Humans; Kanamycin; Mice; Staphylococcus aureus | 1980 |
[Combined cefotaxime-amikacin treatment of infectious episodes in acute leukaemia patients with therapeutically-induced bone marrow aplasia (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Humans; Kanamycin; Leukemia; Middle Aged | 1981 |
[An empirical combination of antibiotics used in aplasias during chemotherapy for acute malignant hemopathies (author's transl)].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacteria, Anaerobic; Bacterial Infections; Child; Drug Evaluation; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Fever; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Piperacillin; Pseudomonas Infections; Random Allocation; Staphylococcal Infections | 1984 |
[Experience in combination therapy with amikacin and cephapirin for infections complicated with acute leukemia during induction chemotherapy].
Topics: Acute Disease; Adult; Amikacin; Antineoplastic Agents; Bacterial Infections; Cephalosporins; Cephapirin; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Male; Middle Aged | 1984 |
Effect of 'high-dose' amikacin in children.
Topics: Adolescent; Amikacin; Bacterial Infections; Child; Child, Preschool; Creatinine; Deafness; Hearing; Hearing Loss, Bilateral; Humans; Infant; Kanamycin; Kidney; Time Factors | 1984 |
[Penetration of amikacin into the anterior chamber of the human eye].
Topics: Aged; Amikacin; Anterior Chamber; Aqueous Humor; Bacterial Infections; Conjunctiva; Eye Diseases; Female; Humans; Injections; Injections, Intravenous; Kanamycin; Kinetics; Male; Middle Aged | 1984 |
In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Humans; Kanamycin; Microbial Sensitivity Tests | 1984 |
In vitro and in vivo antibacterial activities of K-4619, a new semisynthetic aminoglycoside.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chromatography, Thin Layer; Culture Media; Dibekacin; Drug Resistance, Microbial; Gentamicins; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1984 |
Progressive increase in antibiotic resistance of gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Gentamicins; Hospitals, Military; Humans; Tobramycin | 1983 |
[Clinical effect of amikacin. Report of 31 cases].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Child; Ear; Female; Humans; Kanamycin; Kidney; Male; Middle Aged | 1983 |
Empiric antibiotic therapy with an amikacin-carbenicillin-cefoxitin combination in granulocytopenic febrile patients--a clinical report.
Topics: Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Carbenicillin; Cefoxitin; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Leukemia; Lymphoma; Male; Middle Aged | 1983 |
Replacement of gentamicin by amikacin as a means of decreasing gentamicin resistance of gram-negative rods in a neonatal intensive care unit.
Topics: Amikacin; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Kanamycin | 1983 |
[Clinical evaluation of ototoxicity associated with intravenous drip infusion of amikacin].
Topics: Adolescent; Adult; Amikacin; Audiometry, Pure-Tone; Bacterial Infections; Child; Ear; Female; Hearing; Humans; Infusions, Parenteral; Kanamycin; Kidney; Male; Middle Aged; Otorhinolaryngologic Diseases | 1983 |
[Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
Topics: Amikacin; Bacteria; Bacterial Infections; Drug Interactions; Drug Resistance, Microbial; Ear; Gentamicins; Humans; Kanamycin; Kidney; Tobramycin | 1983 |
BB-K 122: in vitro and in vivo activity against ocular pathogens.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Eye Diseases; Female; In Vitro Techniques; Kanamycin; Male; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcus aureus; Streptococcus | 1981 |
Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli.
Topics: Amikacin; Aminoglycosides; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Humans; Kanamycin; Neoplasms; Pseudomonas aeruginosa; Time Factors | 1982 |
The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Netilmicin; Sisomicin; Streptomycin; Tobramycin | 1983 |
The in-vitro activity of O-demethylfortimicin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Gentamicins; Humans; Microbial Sensitivity Tests | 1983 |
Treatment of cytotoxic drug-related infections.
Topics: Adult; Aged; Amikacin; Antineoplastic Agents; Bacteria; Bacterial Infections; Cefuroxime; Drug Therapy, Combination; Female; Humans; Male; Middle Aged | 1983 |
[Fundamental and clinical studies on sisomicin in children (author's transl)].
Topics: Acute Disease; Age Factors; Amikacin; Ampicillin; Bacteria; Bacterial Infections; Cefazolin; Child; Child, Preschool; Drug Evaluation; Female; Gentamicins; Humans; Infant; Male; Penicillin Resistance; Pyelitis; Sisomicin; Time Factors | 1980 |
[Bacteriological evaluation of netilmicin].
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Carbenicillin; Dibekacin; Drug Evaluation, Preclinical; Drug Synergism; Gentamicins; Mice; Netilmicin; Penicillin Resistance | 1982 |
[Experience of amikacin intravenous drip infusion (author's transl)].
Topics: Adult; Aged; Amikacin; Bacterial Infections; Drug Evaluation; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia, Myeloid, Acute; Male; Middle Aged | 1980 |
Empiric treatment of infections in granulocytopenic patients with acute leukemia: a study on amikacin-carbenicillin-cotrimoxazole.
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Sepsis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
Aminoglycoside dosing in renal transplant patients. Comparison of nomogram and individualized pharmacokinetic methods in patients with shifting renal function.
Topics: Adolescent; Adult; Amikacin; Aminoglycosides; Bacterial Infections; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Kidney Transplantation; Labyrinth Diseases; Male; Middle Aged; Pseudomonas Infections | 1982 |
Intraventricular cerebrospinal fluid antibiotic concentrations in patients with intraventricular infections.
Topics: Amikacin; Bacterial Infections; Brain Diseases; Cephalothin; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Chloramphenicol; Drainage; Female; Humans; Infant; Infant, Newborn; Injections, Intravenous; Kanamycin; Male; Penicillins | 1982 |
Renal and Auditory toxic effects of amikacin in children with cancer.
Topics: Adolescent; Amikacin; Bacterial Infections; Child; Child, Preschool; Hearing Loss; Hearing Loss, High-Frequency; Humans; Infant; Kanamycin; Kidney Diseases; Neoplasms | 1982 |
[The combination therapy of amikacin and beta-lactam antibiotic in the severe bacterial infections (author's transl)].
Topics: Adult; Aged; Amikacin; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Kanamycin; Male; Middle Aged; Penicillins | 1982 |
[Clinical experience with non-specific broad-spectrum antibacterial chemotherapy (author's transl)].
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Cefoxitin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillins; Tobramycin | 1982 |
[Experiences with intravenous drip infusion therapy of amikacin for severe infections in patients of hematological disorder].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Kanamycin; Male; Middle Aged | 1982 |
[Infections during induction chemotherapy of acute leukemia and their control V. Clinical evaluation of a large dose of amikacin injected intravenously].
Topics: Adolescent; Adult; Aged; Amikacin; Antineoplastic Agents; Bacterial Infections; Drug Evaluation; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Male; Middle Aged | 1982 |
[Clinical use of amikacin sulfate in the treatment of bacterial infections and prevention of postoperative infections in the orthopedic field].
Topics: Adolescent; Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Kanamycin; Male; Middle Aged; Postoperative Complications; Premedication | 1982 |
The effect of chronologic age on the serum concentrations of amikacin in sick term and premature infants.
Topics: Age Factors; Amikacin; Bacterial Infections; Cross Infection; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Injections, Intravenous; Kanamycin; Microbial Sensitivity Tests | 1981 |
[Treatment of bacterial infection in acute leukemia, quadruple chemotherapy using CFX, AMK, TIPC and LCM (author's transl)].
Topics: Acute Disease; Adult; Amikacin; Bacterial Infections; Cefoxitin; Drug Therapy, Combination; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Lincomycin; Middle Aged; Penicillins; Ticarcillin | 1980 |
[Intravenous administration of amikacin sulfate for the severe infections complicated with hematologic malignancies (author's transl)].
Topics: Amikacin; Bacterial Infections; Drug Evaluation; Female; Gentamicins; Hematologic Diseases; Humans; Infusions, Parenteral; Kanamycin; Middle Aged | 1980 |
[Aminoglycoside drip intravenous infusion for severe infections due to leukemia and hematopoietic tumor patients (author's transl)].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Drug Evaluation; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Male; Middle Aged | 1981 |
Treatment and prevention of bacterial infections during cytostatic chemotherapy.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Blood Transfusion; Carbenicillin; Cephalosporins; Drug Synergism; Granulocytes; Humans; Kanamycin; Neutropenia | 1981 |
[Application of amikacin by intravenous drip infusion (author's transl)].
Topics: Adult; Aged; Amikacin; Bacterial Infections; Female; Humans; Infusions, Parenteral; Kanamycin; Male; Middle Aged | 1981 |
[Laboratory and clinical studies of amikacin intravenous drip infusion for the severe infections complicated with hematologic malignancies (author's transl)].
Topics: Adult; Aged; Amikacin; Bacterial Infections; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Male; Middle Aged | 1981 |
[Amikacin therapy for serious infections in hematopoietic disorders (author's transl)].
Topics: Adolescent; Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Kanamycin; Male; Middle Aged | 1981 |
[Clinical experience of amikacin intravenous drip infusion for digestive organ infection (author's transl)].
Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Child, Preschool; Digestive System Diseases; Drug Evaluation; Female; Humans; Infusions, Parenteral; Kanamycin; Male; Middle Aged; Surgical Wound Infection | 1981 |
[Our experience with amikacin administration in severe burns].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Burns; Child; Child, Preschool; Female; Humans; Kanamycin; Male; Middle Aged | 1980 |
Efficacy of amikacin and ticarcillin as empiric therapy in febrile neutropenic children with cancer.
Topics: Adolescent; Agranulocytosis; Amikacin; Bacterial Infections; Child; Child, Preschool; Evaluation Studies as Topic; Female; Humans; Infant; Kanamycin; Male; Neoplasms; Neutropenia; Penicillins; Ticarcillin | 1981 |
[Clinical experience of amikacin eye lotion (author's transl)].
Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Child; Child, Preschool; Drug Evaluation; Eye Diseases; Female; Humans; Infant; Kanamycin; Male; Middle Aged; Ophthalmic Solutions | 1981 |
[Experience with intravenous drip infusion of amikacin (author's transl)].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Drug Evaluation; Female; Humans; Infusions, Parenteral; Kanamycin; Male; Middle Aged | 1981 |
[Clinical evaluation of amikacin in severe infections with hematological malignant diseases (author's transl)].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Lymphoma; Male; Middle Aged | 1981 |
The effect of peritoneal dialysis of the pharmacokinetics of amikacin.
Topics: Aged; Amikacin; Bacterial Infections; Body Weight; Female; Half-Life; Humans; Kanamycin; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Peritoneal Dialysis | 1980 |
[Modern trends in antibiotic therapy of difficult infections: amikacin sulfate. A meeting held in Naples with Professor Fernando De Ritis as Chairman].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Humans; Kanamycin | 1980 |
Effect on the renal function of UK 18892.
Topics: Aged; Amikacin; Bacterial Infections; Female; Glomerular Filtration Rate; Humans; Kanamycin; Kidney; Male; Middle Aged | 1980 |
Prevalence of gentamicin- and amikacin-resistant bacteria in sink drains.
Topics: Amikacin; Bacteria; Bacterial Infections; Cross Infection; Disease Reservoirs; Drainage, Sanitary; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Species Specificity; Water Microbiology | 1980 |
In vitro and in vivo antimicrobial activities of sporaricin A, a new aminoglycoside.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dibekacin; Gentamicins; Male; Mice | 1980 |
[Amikacin in therapy].
Topics: Amikacin; Bacterial Infections; Humans; Kanamycin | 1980 |
[Unexpected infectious syndromes with severe leukopenia during anticancer chemotherapy. Results of antibiotic treatment "on demand"].
Topics: Amikacin; Amoxicillin; Antineoplastic Agents; Bacterial Infections; Humans; Kanamycin; Leukopenia | 1980 |
Use of antibiotic-impregnated polymethyl methacrylate for treatment of an open radial fracture in a horse.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Bone Screws; Casts, Surgical; Cefazolin; Cephalosporins; Chemotherapy, Adjuvant; Drug Implants; Female; Horses; Methylmethacrylates; Pregnancy; Pregnancy Complications; Radius Fractures; Splints | 1995 |
Choice of antibiotics for empiric treatment of serious infections.
Topics: Amikacin; Bacterial Infections; Ciprofloxacin; Gentamicins; Humans; Microbial Sensitivity Tests | 1994 |
Predictive performance of two software packages (USC*PACK PC and Abbott PKS system) for the individualization of amikacin dosage in intensive care unit patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Bayes Theorem; Creatinine; Critical Care; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Computer-Assisted; Female; Forecasting; Humans; Male; Metabolic Clearance Rate; Middle Aged; Software | 1994 |
[Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Cefoperazone; Drug Evaluation; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Male; Middle Aged; Sulbactam | 1993 |
Ceftriaxone versus ceftazidime plus aminoglycoside therapy for infections in patients with neutropenia after cytotoxic chemotherapy. Short communication.
Topics: Amikacin; Antineoplastic Agents; Bacterial Infections; Candidiasis; Catheterization, Central Venous; Catheterization, Peripheral; Ceftazidime; Ceftriaxone; Drug Therapy, Combination; Hearing; Humans; Kidney; Leukemia; Lymphoma; Neutropenia; Retrospective Studies | 1993 |
[A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Leukocyte Count; Male; Middle Aged; Neutrophils; Sulbactam | 1993 |
[Severe diffuse facial cellulitis].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Bacterial Infections; Cause of Death; Cellulitis; Child; Drug Therapy, Combination; Face; Female; Forecasting; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Neck; Penicillins; Piperacillin; Premedication; Risk Factors; Treatment Outcome | 1997 |
Aerosolized antimicrobials: another look.
Topics: Aerosols; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cytokines; Humans; Lung; Lung Diseases; Nebulizers and Vaporizers; Respiration, Artificial; Tobramycin; Ventilators, Mechanical | 1998 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas | 1998 |
Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy.
Topics: Adult; Aged; Ambulatory Care; Amikacin; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftriaxone; Cerebral Hemorrhage; Cross Infection; Drug Therapy, Combination; Emergency Service, Hospital; Female; Fever; Hospitalization; Humans; Idarubicin; Incidence; Length of Stay; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neutropenia; Remission Induction; Tretinoin | 1999 |
Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Europe; Gentamicins; Hospitals, University; Humans; Microbial Sensitivity Tests; Prevalence; Sentinel Surveillance; Tobramycin | 1999 |
Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit.
Topics: Adult; Ambulatory Care; Amikacin; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftriaxone; Cerebral Hemorrhage; Clinical Trials as Topic; Drug Therapy, Combination; Emergency Service, Hospital; Fever; Hospitalization; Humans; Immunocompromised Host; Italy; Leukemia, Myeloid; Leukocyte Count; Middle Aged; Mycoses; Neutropenia; Staphylococcal Infections | 1999 |
Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models.
Topics: Amikacin; Bacterial Infections; Body Weight; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Kidney | 2001 |
Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Creatinine; Drug Administration Schedule; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Risk Factors | 2002 |
[12th Bristol Symposium. Amikacin: its role in hospital antibiotic therapy. Monte-Carlo, 1-3 March 1979].
Topics: Amikacin; Animals; Bacterial Infections; Congresses as Topic; France; Humans; Kanamycin | 1979 |
Amikacin.
Topics: Amikacin; Bacterial Infections; Drug Evaluation; Gentamicins; Humans; Kanamycin | 1977 |
Amikacin.
Topics: Amikacin; Bacterial Infections; Biological Availability; Gentamicins; Humans; Kanamycin | 1977 |
In vitro antibacterial activity of four aminoglycosides and two semisynthetic penicillins on fresh clinical isolates from cancer patients.
Topics: Amikacin; Aminoglycosides; Bacterial Infections; Carbenicillin; Gentamicins; Humans; Microbial Sensitivity Tests; Neoplasms; Netilmicin; Penicillin Resistance; Penicillins; Ticarcillin; Tobramycin | 1979 |
[Experience in combination therapy with amikacin, mainly by intravenous drip infusion of a large dose, for infections in acute leukaemia patients (author's transl)].
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cephacetrile; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia, Myeloid, Acute; Male; Middle Aged; Pneumonia; Sulbenicillin | 1979 |
Aminoglycoside nephrotoxicity: comparative assessment in critically ill patients.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Critical Care; Gentamicins; Humans; Kidney; Prospective Studies; Tobramycin | 1979 |
[Amikacin in the treatment of febrile complications occurring during the neutropenic phase of acute hemopathies].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Female; Fever; Humans; Kanamycin; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia | 1979 |
Clinical experience with amikacin, a new aminoglycoside antibiotic.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Male; Middle Aged; Pseudomonas Infections | 1977 |
Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Ear; Gentamicins; Humans; Kanamycin; Middle Aged; Pseudomonas; Sepsis; Serratia marcescens; Tobramycin | 1977 |
Amikacin in gram-negative paediatric infections.
Topics: Adolescent; Amikacin; Bacterial Infections; Child; Child, Preschool; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Infant; Infant, Newborn; Kanamycin; Klebsiella Infections; Male; Respiratory Tract Infections; Skin Diseases; Urinary Tract Infections | 1978 |
Antibiotic penetration of synovial fluid in infected and normal knee joints.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cefazolin; Cefoxitin; Cephalothin; Escherichia coli Infections; Gentamicins; Humans; Joint Diseases; Knee Joint; Rabbits; Synovial Fluid | 1978 |
[Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)].
Topics: Amikacin; Bacteria; Bacterial Infections; Cefazolin; Cefoxitin; Cephalosporins; Drug Synergism; Escherichia coli; Humans; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus vulgaris; Time Factors | 1978 |
Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; In Vitro Techniques; Infant; Kanamycin; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Serratia marcescens; Urinary Tract Infections | 1978 |
Clinical evaluation of netilmicin therapy in serious infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Netilmicin; Sepsis; Urinary Tract Infections | 1979 |
Empiric therapy for infections in granulocytopenic cancer patients: continuous infusion of amikacin plus cephalothin.
Topics: Acute Disease; Amikacin; Bacterial Infections; Cephalothin; Drug Therapy, Combination; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Hodgkin Disease; Humans; Infusions, Parenteral; Kanamycin; Leukemia | 1979 |
Antibiotic level by radioimmunoassay: part one-amikacin.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Child; Child, Preschool; Female; Humans; Infant; Kanamycin; Male; Middle Aged; Radioimmunoassay | 1979 |
Pharmacokinetics of amikacin in infants and pre-school children.
Topics: Age Factors; Amikacin; Bacterial Infections; Body Weight; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Infant, Newborn; Injections, Intramuscular; Injections, Intravenous; Kanamycin; Male; Time Factors | 1979 |
Laboratory evaluation of amikacin susceptibility testing by the AutoBac I system.
Topics: Amikacin; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Humans; Kanamycin; Microbial Sensitivity Tests; Species Specificity | 1979 |
Comments on current antibiotic therapy.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clindamycin; Drug Combinations; Gentamicins; Humans; Microbial Sensitivity Tests; Minocycline; Nafcillin; Otorhinolaryngologic Diseases; Sulfamethoxazole; Surgical Procedures, Operative; Ticarcillin; Tobramycin; Trimethoprim | 1979 |
Amikacin dosage in the preterm newborn.
Topics: Amikacin; Bacterial Infections; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Male; Radioimmunoassay | 1979 |
Amikacin: in vitro bacteriological studies, levels in human serum, lung and heart tissue, and clinical results.
Topics: Amikacin; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Female; Gentamicins; Humans; Kanamycin; Lung; Male; Myocardium | 1979 |
[Clinical and laboratory evaluation of amikacin].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged | 1979 |
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 1979 |
Amikacin pharmacokinetics in pediatric patients with malignancy.
Topics: Adolescent; Amikacin; Bacterial Infections; Blood Urea Nitrogen; Child; Child, Preschool; Creatinine; Female; Half-Life; Humans; Infant; Infusions, Parenteral; Kanamycin; Kinetics; Male; Neoplasms | 1979 |
[Our experience with amikacin in gastrointestinal surgery].
Topics: Amikacin; Bacterial Infections; Digestive System Surgical Procedures; Humans; Kanamycin; Microbial Sensitivity Tests; Postoperative Complications | 1979 |
[Amikacin in oncologic pelvic surgery].
Topics: Amikacin; Bacterial Infections; Female; Humans; Kanamycin; Male; Middle Aged; Postoperative Complications; Rectal Neoplasms; Urologic Neoplasms; Uterine Neoplasms | 1979 |
[Amikacin in the child: efficacy, tolerance, effects on the intestinal microbial ecosystem].
Topics: Amikacin; Bacterial Infections; Child; Child, Preschool; Drug Tolerance; Humans; Infant; Infant, Newborn; Intestines; Kanamycin; Microbial Sensitivity Tests | 1979 |
[Value of measurement of amikacin levels in the management of antibiotic therapy in intensive care (71 estimations)].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Child; Creatinine; Critical Care; Female; Humans; Kanamycin; Kinetics; Male; Middle Aged | 1979 |
Amikacin therapy for serious gram-negative infection.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Kanamycin; Kidney; Klebsiella Infections; Middle Aged; Pseudomonas Infections; Sepsis | 1977 |
Evaluation of amikacin sulfate (Amikin). A new aminoglycoside antibiotic.
Topics: Amikacin; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Drug Synergism; Humans; Immunosuppression Therapy; Kanamycin | 1977 |
3'-Deoxyamikacin and 3',4'-dideoxyamikacin and their antibacterial activities.
Topics: Amikacin; Bacteria; Bacterial Infections; Humans; Kanamycin; Microbial Sensitivity Tests | 1979 |
Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Female; Kanamycin; Mice; Microbial Sensitivity Tests | 1977 |
New developments in antimicrobial therapy.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Gentamicins; Humans; Ticarcillin; Tobramycin | 1978 |
Antimicrobial therapy in the neonate.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Meningitis; Penicillins; Skin Diseases, Infectious; Tobramycin; Urinary Tract Infections | 1978 |
Amikacin therapy of serious gram-negative bacillary infections in chronic hemodialysis patients.
Topics: Amikacin; Bacterial Infections; Female; Humans; Kanamycin; Male; Middle Aged; Renal Dialysis | 1978 |
[The clinical view of aminoglycoside antibiotics].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Gentamicins; Humans; Sisomicin; Tobramycin | 1978 |
Prudent use of the aminoglycosides.
Topics: Amikacin; Aminoglycosides; Bacteria; Bacterial Infections; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Drug Therapy, Combination; Ear; Gentamicins; Humans; Kanamycin; Kidney; Tobramycin | 1978 |
The necessity of increased doses of amikacin in burn patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Burns; Creatinine; Half-Life; Humans; Infant; Kanamycin; Middle Aged | 1978 |
[Clinical and bacteriological evaluation of Amikin (Amikacin sulfate) by Bristol-Myers].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Drug Resistance, Microbial; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged | 1978 |
Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Bronchitis; Chronic Disease; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 1976 |
Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
Topics: Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Bacterial Infections; Enterobacteriaceae Infections; Humans; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections | 1976 |
Use of Amikacin in a hospital for children: microbiological and clinical studies.
Topics: Amikacin; Aminoglycosides; Bacterial Infections; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Kanamycin; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections | 1976 |
Symposium perspective.
Topics: Amikacin; Bacterial Infections; Drug Resistance, Microbial; Humans; Kanamycin | 1977 |
Treatment of hospita-acquired infections with amikacin.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cross Infection; Female; Humans; Kanamycin; Male; Middle Aged; Proteus; Proteus Infections; Urinary Tract Infections | 1977 |
Amikacin treatment of pulmonary infections involving gentamicin-resistant gram-negative bacilli.
Topics: Amikacin; Bacteria; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Lung Diseases | 1977 |
An overview of pediatric experience with amikacin.
Topics: Amikacin; Bacterial Infections; Child; Cross Infection; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin | 1977 |
Effects of gestational age, birth weight, and hypoxemia on pharmacokinetics of amikacin in serum of infants.
Topics: Amikacin; Bacterial Infections; Birth Weight; Female; Gestational Age; Humans; Hypoxia; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Male | 1977 |
Use of aminoglycosides in surgical infections.
Topics: Abscess; Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Female; Gentamicins; Humans; Infant; Male; Middle Aged; Peritonitis; Sepsis; Sisomicin; Surgical Wound Infection; Tobramycin; Wound Infection | 1976 |
Amikacin in newborn infants: comparative pharmacology with kanamycin and clinical efficacy in 45 neonates with bacterial diseases.
Topics: Amikacin; Bacterial Infections; Humans; Infant, Newborn; Kanamycin | 1976 |
Amikacin in treatment of infections caused by gram-negative bacteria resistant to gentamicin and other aminoglycosides: clinical and bacteriologic results.
Topics: Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kanamycin; Male; Micrococcus; Middle Aged; Respiratory Tract Infections; Urinary Tract Infections | 1976 |
Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies.
Topics: Amikacin; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fetal Blood; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Kidney Failure, Chronic; Pregnancy; Pregnancy Complications, Infectious; Pseudomonas Infections; Urinary Tract Infections | 1976 |
Preliminary clinical trial with amikacin in chronic recurrent gram-negative bacterial infections refractory to other antimicrobial agents.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Chronic Disease; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Peritonitis; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1976 |
Clinical and laboratory studies with amikacin in newborns, infants, and children.
Topics: Adolescent; Amikacin; Bacterial Infections; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Male; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections | 1976 |
Amikacin for treatment of infections in patients with malignant diseases.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Blood Cell Count; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Neoplasms; Neutrophils; Pseudomonas Infections | 1976 |
Amikacin therapy for severe gram-negative sepsis: efficacy in infections involving gentamicin-resistant organisms.
Topics: Amikacin; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Kanamycin; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections; Sepsis | 1976 |
Bacterial prostatitis treated by local antibiotics.
Topics: Amikacin; Bacterial Infections; Cefazolin; Cephalosporins; Follow-Up Studies; Gentamicins; Humans; Injections; Kanamycin; Male; Prostatitis | 1976 |
Amikacin.
Topics: Amikacin; Bacterial Infections; Drug Resistance, Microbial; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; Kanamycin; Leukopenia; Tobramycin | 1976 |
[Pharmacokinetics and clinical experiences with a new aminoglycoside antibioticum: amikacin].
Topics: Adult; Amikacin; Bacterial Infections; Cross Infection; Drug Evaluation; Female; Humans; Kanamycin; Male; Middle Aged | 1976 |
Amikacin therapy for serious gram-negative bacillary infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Ear, Inner; Female; Humans; Kanamycin; Kidney; Male; Middle Aged; Osteomyelitis; Peritonitis; Pneumonia; Sepsis; Urinary Tract Infections | 1975 |
In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbenicillin; Drug Synergism; Gentamicins; Kanamycin; Species Specificity; Tobramycin | 1976 |
Treatment of acutely infected arthroplasties with incision, drainage, and local antibiotics delivered via an implantable pump.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Drainage; Female; Hip Joint; Hip Prosthesis; Humans; Infusion Pumps, Implantable; Knee Joint; Knee Prosthesis; Male; Middle Aged; Prosthesis-Related Infections; Radiography; Treatment Outcome | 1992 |
[Bacteriology of neonatal septicemia in Dakar].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Incidence; Infant, Newborn; Klebsiella Infections; Male; Senegal; Staphylococcal Infections; Streptococcal Infections | 1992 |
Relation between pharmacokinetics of amikacin sulfate and sepsis score in clinically normal and hospitalized neonatal foals.
Topics: Age Factors; Amikacin; Animals; Animals, Newborn; Bacteremia; Bacterial Infections; Breeding; Creatinine; Female; Half-Life; Horse Diseases; Horses; Injections, Intravenous; Male; Tissue Distribution | 1992 |
Netilmicin plus ceftriaxone versus amikacin plus ceftriaxone in the treatment of infections in granulocytopenic patients.
Topics: Adult; Agranulocytosis; Amikacin; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Netilmicin; Retrospective Studies | 1992 |
Amikacin dosing in neonates: evaluation of a dosing chart based on population pharmacokinetic data.
Topics: Age Factors; Amikacin; Bacterial Infections; Data Collection; Drug Administration Schedule; Evaluation Studies as Topic; Female; Glomerular Filtration Rate; Half-Life; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Metabolic Clearance Rate; Prospective Studies | 1991 |
Ceftriaxone plus amikacin in neutropenic patients: a report on 100 cases.
Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftriaxone; Child; Drug Therapy, Combination; Humans; Leukemia; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia | 1991 |
Once daily amikacin. Report of a meeting.
Topics: Amikacin; Bacterial Infections; Drug Administration Schedule; Gram-Negative Bacteria; Humans | 1991 |
Serum concentrations and safety of single daily dosing of amikacin in children undergoing bone marrow transplantation.
Topics: Adolescent; Agranulocytosis; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Child; Child, Preschool; Creatinine; Drug Administration Schedule; Drug Therapy, Combination; Female; Hearing; Humans; Kidney; Male; Microbial Sensitivity Tests | 1991 |
Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients: a pilot study.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Hearing; Humans; Male; Middle Aged; Pilot Projects; Vancomycin | 1991 |
Single daily dose amikacin in paediatric patients with severe gram-negative infections.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Creatinine; Drug Administration Schedule; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Infant; Lactams; Prospective Studies; Pseudomonas Infections | 1991 |
Once daily dosing of aminoglycoside: one step forward.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Lactams | 1991 |
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
Topics: Amikacin; Animals; Bacterial Infections; Bacteroides fragilis; Carbapenems; Ceftazidime; Cilastatin; Ciprofloxacin; Dipeptidases; Drug Therapy, Combination; Escherichia coli; Female; Imipenem; Klebsiella pneumoniae; Metronidazole; Mice; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Thienamycins | 1991 |
Biochemical and pharmacodynamic studies of simple renal cyst fluids in relation to infection.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Body Fluids; Drainage; Escherichia coli Infections; Female; Humans; Inhalation; Kidney Diseases, Cystic; Male; Middle Aged | 1991 |
Local antibiotic delivery in the treatment of bone and joint infections.
Topics: Acute Disease; Adolescent; Aged; Amikacin; Bacterial Infections; Bone Diseases; Chronic Disease; Female; Hip Prosthesis; Humans; Infusion Pumps, Implantable; Joint Diseases; Knee Prosthesis; Male; Osteomyelitis | 1991 |
Amikacin pharmacokinetics: wide interpatient variation in 98 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Child; Child, Preschool; Creatinine; Female; Gram-Negative Bacteria; Half-Life; Humans; Infant; Male; Metabolic Clearance Rate; Middle Aged; Regression Analysis | 1991 |
[The results of antibiotic therapy in acute severe pneumonia dependent on the initial severity].
Topics: Acute Disease; Amikacin; Bacterial Infections; Drug Combinations; Female; Humans; Male; Middle Aged; Piperacillin; Pneumonia; Prognosis | 1990 |
A prospective study of long-term use of amikacin in a paediatrics department. Indications, administration, side-effects, bacterial isolates and resistance.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Monitoring, Physiologic; Prospective Studies | 1990 |
[Amikacin in the treatment of infectious-inflammatory diseases in patients at a therapeutic hospital].
Topics: Amikacin; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Endocarditis, Bacterial; Humans; Inflammation; Respiratory Tract Infections; Urinary Tract Infections | 1990 |
[Infectious complications after surgery of esophageal pathology. Apropos of 60 cases].
Topics: Aged; Amikacin; Bacterial Infections; Cefoxitin; Esophageal Diseases; Female; Gram-Negative Bacteria; Humans; Lung Diseases; Male; Middle Aged; Parenteral Nutrition; Postoperative Complications; Premedication; Prospective Studies; Urinary Tract Infections | 1989 |
Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Enterococcus faecalis; Escherichia coli; Female; Imipenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Norfloxacin; Protein Binding; Pseudomonas aeruginosa; Staphylococcus aureus | 1989 |
[Combined antibacterial therapy of infectious complications in oncological patients].
Topics: Amikacin; Bacterial Infections; Carbenicillin; Cefazolin; Drug Therapy, Combination; Humans; Immune Tolerance; Neoplasms; Opportunistic Infections | 1989 |
Ceftriaxone plus amikacin in a single daily dose as empiric antibiotic therapy in granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Humans; Middle Aged | 1989 |
[Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Cephamycins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Leukemia; Male; Middle Aged; Respiratory Tract Infections; Urinary Tract Infections | 1989 |
Combination antibiotic treatment of chemotherapy-induced neutropenia in non-leukemic patients.
Topics: Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Clindamycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies | 1989 |
Where has all the amikacin gone?
Topics: Adult; Amikacin; Bacterial Infections; Critical Care; Female; Humans | 1989 |
Bacteriostatic and bactericidal in-vitro activity of meropenem against clinical isolates, including Mycobacterium avium complex.
Topics: Amikacin; Bacteria; Bacterial Infections; Carbapenems; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Mycobacterium avium Complex; Thienamycins | 1989 |
Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Bacterial Infections; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Kanamycin Kinase; Netilmicin; Nucleotidyltransferases; Phosphotransferases; Population Surveillance; Prospective Studies; Tobramycin | 1986 |
[Infections in neutropenic children with neoplasms. Case series contribution].
Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Leukemia; Lymphoma; Male; Neoplasms; Neutropenia | 1988 |
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Escherichia coli; Female; Kanamycin; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1986 |
Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Klebsiella; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Time Factors; Tobramycin | 1986 |
Surveillance of aminoglycoside resistance. European data.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Belgium; Drug Resistance, Microbial; Europe; Gentamicins; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Netilmicin; Prospective Studies; Pseudomonas aeruginosa; Tobramycin | 1986 |
Pharmacokinetics of pefloxacin and amikacin administered simultaneously to intensive care patients.
Topics: Aged; Amikacin; Bacterial Infections; Drug Interactions; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Pefloxacin | 1988 |
Effects of antimicrobial agents used for therapy of CNS infections on dissociated brain cell cultures.
Topics: Amikacin; Animals; Animals, Newborn; Anti-Bacterial Agents; Bacterial Infections; Brain; Cell Differentiation; Cell Division; Cells, Cultured; Central Nervous System Diseases; Cephalosporins; Chloramphenicol; DNA; Drug Therapy, Combination; Humans; Penicillin G; Proteins; Rats; Rats, Inbred Strains; Streptomycin | 1988 |
[Microorganisms isolated in 54 patients receiving bone marrow transplants and evaluation of their sensitivity to antimicrobial agents].
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Bone Marrow Transplantation; Cefotaxime; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillin Resistance | 1987 |
Control of prosthetic bacterial infection: evaluation of an easily incorporated, tightly bound, silver antibiotic PTFE graft.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Vessel Prosthesis; Dogs; Evaluation Studies as Topic; Female; Oxacillin; Polytetrafluoroethylene; Silver Nitrate; Staphylococcal Infections | 1988 |
Comparison of two versus three daily infusions of cefotaxime plus amikacin in granulocytopenic children.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans | 1988 |
[Empiric therapy with piperacillin plus amikacin in febrile granulocytopenic patients with acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blast Crisis; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Male; Middle Aged; Piperacillin | 1986 |
Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli.
Topics: Amikacin; Animals; Azlocillin; Bacterial Infections; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Evaluation, Preclinical; Female; Gram-Negative Bacteria; Penicillin Resistance; Rabbits | 1987 |
The efficacy of amikacin in the treatment of severe infections in a renal unit.
Topics: Amikacin; Bacteria; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Hospital Units; Humans; Kidney Diseases; Male; Middle Aged; Penicillins; Sepsis | 1987 |
Five years of experience with the exclusive use of amikacin in a neonatal intensive care unit.
Topics: Amikacin; Bacterial Infections; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests | 1987 |
[Combined clinical effect of amikacin and cefoxitin in patients with severe infections complicated by hematological diseases].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cefoxitin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged | 1987 |
Clinical experience with Timentin in severe hospital infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Clavulanic Acids; Cross Infection; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Hemorrhagic Disorders; Humans; Male; Middle Aged; Pancreatitis; Penicillin Resistance; Penicillins; Ticarcillin | 1986 |
Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients.
Topics: Adult; Aged; Agranulocytosis; Amikacin; Bacteria; Bacterial Infections; Clavulanic Acids; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Male; Middle Aged; Neoplasms; Penicillin Resistance; Penicillins; Sepsis; Ticarcillin | 1986 |
The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, and sisomicin.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Gentamicins; Humans; Netilmicin; Sisomicin; Streptomycin; Tobramycin | 1987 |
[Fundamental study of amikacin in the newborn].
Topics: Amikacin; Bacterial Infections; Exchange Transfusion, Whole Blood; Female; Humans; Infant, Newborn; Male | 1987 |
[Studies on the intravenous administration of amikacin to neonates].
Topics: Age Factors; Amikacin; Bacterial Infections; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Saliva | 1987 |
[Pharmacokinetic and clinical studies on amikacin in neonates].
Topics: Age Factors; Amikacin; Bacterial Infections; Half-Life; Humans; Infant, Newborn; Infusions, Intravenous; Injections, Intramuscular | 1987 |
[Clinico-bacteriological evaluation of the effectiveness of amikacin in chronic bronchopulmonary diseases and mucoviscidosis in children].
Topics: Adolescent; Amikacin; Bacterial Infections; Bronchiolitis; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Infant; Pneumonia | 1987 |
Management of sepsis in the elderly.
Topics: Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pneumonia; Risk; Shock, Septic; Urinary Tract Infections | 1986 |
Combination therapy and monotherapy in the treatment of severe infection in the immunocompromised host.
Topics: Agranulocytosis; Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Immune Tolerance; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus | 1986 |
In vitro models for the study of combination antibiotic therapy in neutropenic patients.
Topics: Agranulocytosis; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Carbenicillin; Cefazolin; Cephalothin; Drug Therapy, Combination; Gentamicins; Humans; Models, Biological; Neutropenia; Pseudomonas Infections; Risk | 1986 |
Combination antibiotic therapy in pediatrics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Immunologic Deficiency Syndromes; Infant; Infant, Newborn; Kanamycin; Lactams; Neutropenia; Peritoneal Dialysis, Continuous Ambulatory; Pseudomonas Infections; Risk | 1986 |
Treatment of cerebrospinal fluid leaks and gram-negative bacillary meningitis with large doses of intrathecal amikacin and systemic antibiotics.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cerebrospinal Fluid; Cerebrospinal Fluid Rhinorrhea; Gram-Negative Bacteria; Humans; Injections, Spinal; Kanamycin; Male; Meningitis; Middle Aged; Spinal Cord Diseases | 1986 |
Intravitreal amikacin in the treatment of bacterial endophthalmitis.
Topics: Aged; Amikacin; Bacterial Infections; Child, Preschool; Female; Humans; Male; Middle Aged; Panophthalmitis; Vitreous Body | 1986 |
[Adaptation of amikacin dosages for the premature infant].
Topics: Amikacin; Bacterial Infections; Drug Administration Schedule; Humans; Infant, Newborn; Infant, Premature, Diseases; Kinetics | 1986 |
[The use of aminosides in the burn patient].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Burns; Humans; Netilmicin; Tobramycin | 1986 |
Antibacterial activity and ototoxicity in guinea pigs, and nephrotoxicity in rats of arbekacin.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Dibekacin; Drug Resistance, Microbial; Ear, Inner; Guinea Pigs; Injections, Intramuscular; Kanamycin; Kidney; Male; Rats; Rats, Inbred Strains; Reflex; Structure-Activity Relationship | 1986 |
Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use.
Topics: Acetyltransferases; Amikacin; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Kanamycin; New York; Pseudomonas aeruginosa; Pseudomonas Infections; R Factors | 1985 |
Aminoglycosides and ampicillin to newborn infants. Kinetics and dosage calculations.
Topics: Amikacin; Amino Acids; Ampicillin; Bacterial Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Stability; Drug Therapy, Combination; Gentamicins; Humans; Infant, Newborn; Kanamycin; Kinetics; Parenteral Nutrition; Prospective Studies | 1985 |
Factors associated with nephrotoxicity and clinical outcome in patients receiving amikacin.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Creatinine; Female; Humans; Kanamycin; Kidney Diseases; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged | 1986 |
Clinical and microbiologic consequences of amikacin use during a 42-month period.
Topics: Age Factors; Aged; Amikacin; Bacterial Infections; Catheterization; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Hospital Bed Capacity, 500 and over; Hospitalization; Hospitals, Veterans; Humans; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Tennessee; Tobramycin | 1986 |
Gentamicin, tobramycin, amikacin, and netilmicin levels in tears following intravenous administration.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Female; Gentamicins; Humans; Infusions, Parenteral; Kanamycin; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Netilmicin; Tears; Tobramycin | 1985 |
Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Combinations; Female; Infusions, Parenteral; Kinetics; Pseudomonas Infections; Rats; Rats, Inbred Strains; Ticarcillin | 1985 |
[Empiric therapy with piperacillin plus amikacin for febrile patients with cancer--with emphasis on granulocytopenia].
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kanamycin; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Neoplasms; Piperacillin | 1985 |
Treatment of pediatric infections with amikacin as first-line aminoglycoside.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Chicago; Child; Drug Resistance, Microbial; Drug Synergism; Drug Utilization; Gram-Negative Bacteria; Hospitals, Pediatric; Humans; Infant, Newborn; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Pediatrics; Pseudomonas; Staphylococcus | 1985 |
[Clinical evaluation of amikacin by intravenous drip infusion for infections in the field of internal medicine].
Topics: Acinetobacter Infections; Adult; Aged; Amikacin; Bacterial Infections; Cystitis; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Sepsis | 1985 |
[Experimental study of the antibacterial activity and chemotherapeutic effectiveness of amikacin sulfate].
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Kanamycin; Mice; Microbial Sensitivity Tests | 1985 |